Introduction {#s1}
============

Sarcomeres are the stereotyped force producing mini-machines present in all striated muscles of bilaterians. They are built of three filament types arrayed in a pseudo-crystalline order: actin filaments are cross-linked with their plus ends at the sarcomeric Z-disc and face with their minus ends towards the sarcomere center. In the center, symmetric bipolar muscle myosin filaments, anchored at the M-line, can interact with the actin filaments. Myosin movement towards the actin plus ends thus produces force during sarcomere shortening. Both filament types are permanently linked by a third filament type, the connecting filaments, formed of titin molecules ([@bib25]; [@bib36]). A remarkable feature of sarcomeres is their stereotyped size, ranging from 3.0 to 3.4 µm in relaxed human skeletal muscle fibers ([@bib18]; [@bib43]; [@bib58]). Even more remarkable, the length of each bipolar myosin filament is 1.6 µm in all mature sarcomeres of vertebrate muscles, requiring about 300 myosin hexamers to assemble per filament ([@bib26]; [@bib81]).

Human muscle fibers can be several centimetres in length and both ends of each fiber need to be stably connected to tendons to achieve body movements. As sarcomeres are only a few micrometres in length, many hundreds need to assemble into long linear myofibrils that span from one muscle end to the other and thus enable force transmission from the sarcomeric series to the skeleton ([@bib38]). Thus far, we have a very limited understanding of how sarcomeres initially assemble into long immature myofibrils during muscle development to exactly match the length of the mature muscle fiber ([@bib74]). In particular, we would like to understand how such sarcomeres mature to the very precise stereotyped machines present in mature muscle fibers.

Across evolution, both the pseudo-crystalline regularity of sarcomeres as well as their molecular components are well conserved ([@bib18]; [@bib82]). Thus, *Drosophila* is a valid model to investigate the biogenesis of sarcomeres as well as their maturation. In particular, the large indirect flight muscles (IFMs) that span the entire fly thorax are an ideal model system to investigate mechanisms of myofibrillogenesis. They contain thousands of myofibrils consisting of 3.2 µm long sarcomeres ([@bib69]; [@bib75]).

Like all *Drosophila* adult muscles, IFMs are formed during pupal development from a pool of undifferentiated myoblasts called adult muscle precursors (AMPs) ([@bib3]). From 8 hr after puparium formation (APF), these AMPs either fuse with themselves (for the dorso-ventral flight muscles, DVMs) or with remodelled larval template muscles (for the dorso-longitudinal flight muscles, DLMs) to form myotubes ([@bib17]; [@bib19]). These myotubes develop dynamic leading edges at both ends and initiate attachment to their respective tendon cells at 12 to 16 hr APF ([@bib86]). These attachments mature and mechanical tension is built up in the myotubes, followed by the formation of the first immature periodic myofibrils at 30 hr APF when the muscle fibers are about 150 µm in length. These immature myofibrils contain the earliest sarcomeres, which are about 1.8 µm in length ([@bib86]). During the remaining 3 days of pupal development, the muscle fibers grow to about 1 mm to fill the entire thorax and sarcomere length increases to a final length of about 3.2 µm in adult flies ([@bib51]; [@bib56]).

After myoblasts have fused to myotubes, the flight muscle specific selector gene *spalt major* (*spalt*, *salm*) is turned on in the developing flight muscle myotubes. Spalt major is responsible for the correct fate determination and development of the flight muscles, which includes the fibrillar flight muscle morphology and the stretch-activated muscle contraction mode ([@bib69]; [@bib78]). It does so by controlling the expression of more than 700 flight muscle specific genes or gene isoforms during development ([@bib76]; [@bib75]). However, how the interplay between all these isoforms instructs the formation of highly regular, pseudo-crystalline sarcomeres in the flight muscle is not understood.

Here, we studied the transcriptional dynamics of flight muscle development in detail. We performed a systematic mRNA-Seq time-course of isolated muscle tissue at eight time points from the myoblast stage until the mature adult muscle stage, generating a transcriptomics resource of developing flight muscle. Bioinformatic analysis of expression dynamics identified two gene clusters that are strongly enriched for sarcomeric genes. The temporal dynamics of these clusters identified a transcriptional transition that is required for sarcomere morphogenesis. We define sarcomere morphogenesis in three sequential although overlapping phases. First, immature myofibrils assemble simultaneously; second, short sarcomeres are added to each myofibril; and third, all sarcomeres mature to their final length and diameter and acquire stretch-sensitivity. Interestingly, the number of myofibrils remains constant, suggesting that every sarcomere progresses through sarcomere maturation. We show that the flight muscle selector gene *spalt major* contributes to the observed transcriptional transition, suggesting that muscle fiber type-specific transcription is continuously required during sarcomere formation and maturation. Together, these findings indicate that precise transcriptional control of the sarcomeric components enables their ordered assembly into sarcomeres and their maturation to pseudo-crystalline regularity.

Results {#s2}
=======

A time-course of indirect flight muscle development {#s2-1}
---------------------------------------------------

To better understand muscle morphogenesis in general and myofibrillogenesis in particular, we focused on the *Drosophila* indirect flight muscles (IFMs). We hypothesised that major morphological transitions during IFM development may be induced by transcriptional changes, thus we aimed to generate a detailed developmental mRNA-Seq dataset from IFMs. IFMs are built from AMPs that adhere to the hinge region of the wing disc epithelium and are labelled with GFP-Gma under *Him* control ([Figure 1A](#fig1){ref-type="fig"}) ([@bib73]). At 16 hr APF, many of these myoblasts have fused to larval template muscles to build the dorsal-longitudinal flight muscle (DLM) myotubes, which initiate attachment to their tendons. At this stage, the DLM myotubes of fibers 3 and 4 have a length of about 300 µm ([Figure 1B](#fig1){ref-type="fig"}). Fusion ceases at about 24 hr APF ([Figure 1C](#fig1){ref-type="fig"}) and attachment matures until 32 hr APF, coinciding with the strong recruitment of βPS-Integrin and the spectraplakin homolog Shortstop (Shot) to the attachment sites. At this stage the myofibers have built up mechanical tension and compacted to a length of about 150 µm, coinciding with the appearance of long Shot-positive tendon extensions that anchor the muscles within the thorax. This important developmental transition is highlighted by the assembly of immature myofibrils visualised by strong F-actin staining throughout the entire muscle fiber ([Figure 1D](#fig1){ref-type="fig"}) ([@bib86]).

![Development of the dorsal longitudinal indirect flight muscles.\
(**A--H**) Time-course of DLM development. (**A**) Myoblasts adhering to the hinge of the larval wing disc were visualised with *Him*-GFP-Gma (green), F-actin was stained with phalloidin (red) and nuclei with DAPI (blue). (**B--H**) Time-course of DLM and myotendinous junction development at 16 hr (**B**), 24 hr (**C**), 32 hr (**D**), 48 hr (**E**), 56 hr (**F**), 72 hr (**G**) and 90 hr APF (**H**). F-actin was stained with phalloidin (red), Shot (green) and βPS-Integrin (blue). DLMs are highlighted in dashed yellow lines in B an C. (**A'''--C'''**) Scheme of the respective developmental stages with myoblasts and muscles in red, tendon cells in blue and wing disc or pupal thorax outline in black. The length of the muscle fibers in indicated in red. For details see text. Scale bar represents 100 µm. (**I**) Temporal summary of known events during myogenesis (red). Samples for mRNA-Seq were collected at time points noted in black.\
10.7554/eLife.34058.004Figure 1---source data 1.This table includes the length measurements of the indirect flight muscle fibers at the indicated stage.](elife-34058-fig1){#fig1}

After 32 hr APF, the myofibers undergo another developmental transition and begin to grow dramatically. They elongate 3-fold to reach a length of about 480 µm by 48 hr APF ([Figure 1E](#fig1){ref-type="fig"}) and about 590 µm by 56 hr APF ([Figure 1F](#fig1){ref-type="fig"}). Concomitantly, the tendon extensions shrink with the myofibers being directly connected to the basal side of the tendon cell epithelium by 72 hr APF ([Figure 1G](#fig1){ref-type="fig"}). At the end of pupal development (90 hr APF), wavy muscle fibers with a length of about 780 µm containing mature myofibrils ([Figure 1H](#fig1){ref-type="fig"}) are present within the thorax.

A transcriptomics resource of indirect flight muscle development {#s2-2}
----------------------------------------------------------------

To quantify transcriptional dynamics across the entire developmental time-course, we focused on the major developmental transitions and isolated mRNA from dissociated myoblasts of dissected or mass-isolated third instar wing discs and from hand-dissected IFMs at 16, 24, 30, 48, 72 and 90 hr APF pupae, and adult flies 1 day after eclosion ([Figure 1I](#fig1){ref-type="fig"}). We performed mRNA-Seq using at least two biological replicates for each time point (see Materials and methods). To identify genes with similar temporal expression profiles, we used Mfuzz ([@bib33]) to cluster standard normalized read counts from all genes expressed above background (12,495 of 13,322 genes). This allowed us to confidently identify 40 distinct genome-wide clusters ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), each of which contains a unique gene set ranging from 155 to 703 members ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). These clusters represent various temporal expression dynamics, with high expression at early (myoblast proliferation and fusion), mid (myotube attachment and myofibril assembly) or late (myofiber growth) myogenesis stages or a combination thereof ([Figure 1I](#fig1){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These distinct patterns suggest a precise temporal transcriptional regulation corresponding to observed morphological transition points.

To verify the mRNA-Seq and cluster analysis, we selected a number of 'indicator' genes with available antibodies or GFP fusion proteins whose expression correlates with important developmental transitions. Twist (Twi) is a myoblast nuclear marker at larval stages and its expression needs to be down-regulated after myoblast fusion in pupae ([@bib1]). We find *twi* mRNA in Mfuzz cluster 27, with high expression in myoblasts until 16 hr APF and a significant down-regulation from 24 hr APF, which we were able to verify with antibody stainings ([Figure 2A--C](#fig2){ref-type="fig"}). The flight muscle fate selector gene *spalt major* (*salm*) ([@bib69]) and its target, the IFM splicing regulator *arrest* (*aret, bruno*) ([@bib75]) are members of cluster 26 and 14, respectively. Expression of both clusters is up-regulated after myoblast fusion at 16 hr APF, which we were able to verify with antibody stainings ([Figure 2D--F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}). The apparent *salm* mRNA peak at 72 hr APF, which does not appear to cause a further protein increase, represents a mere 1.3 fold increase in expression and would need further confirmation as Salm, like many transcription factors, is expressed at low levels. For the initiation of muscle attachment, we selected Kon-tiki (Kon) ([@bib67]; [@bib86]), member of cluster 15, which is transiently up-regulated after myoblast fusion, before it is down-regulated again after 30 hr APF. Consistently, we found Kon-GFP present at muscle attachment sites at 30 hr APF but not at 72 hr APF ([Figure 2G--I](#fig2){ref-type="fig"}). A similar expression peak shifted to slightly later time points is found in cluster 34, which contains *β-tubulin 60D* (*βTub60D*) ([@bib37]). Consistently, we find β-Tub60D-GFP ([@bib63]) expression in IFMs at 30 and 48 hr but not 72 hr APF ([Figure 2J--L](#fig2){ref-type="fig"}). After attachment is initiated, the attachments need to mature and be maintained. As expected, we found the essential attachment components βPS-Integrin (*mys*) and Talin (*rhea*) in clusters that are up-regulated after myoblast fusion until adulthood (clusters 7 and 25, respectively). This is consistent with continuous high protein expression of βPS-Integrin-GFP and Talin-GFP at muscle attachment sites ([Figure 2M--O](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D--F](#fig2s2){ref-type="fig"}). Taken together, these semi-quantitative protein localisation data nicely validate the temporal mRNA dynamics found in the mRNA-Seq data, confirming our methodology.

![Verification of mRNA-Seq time-course by 'indicator' gene expression.\
(**A,D,G,J,M,P,S**) Temporal expression dynamics were evaluated by clustering standard-normal mRNA-seq counts using Mfuzz. Temporal expression profiles are plotted with high membership values in warm colours (red, pink), and lower membership values in cool colours (blue, green). (**B,E,H,K,N,Q,T**) The profile of one 'indicator' gene from each cluster is shown and coloured based on the Mfuzz membership value α. (**C,F,I,L,O,R,U**). Protein expression and localisation dynamics were visualised by antibody staining against Twi (**C**) and Aret (**F**) or against GFP for GFP tagged fosmid reporters for Kon (**I**), β-Tub60D (**L**), βPS-Integrin (*mys*) (**O**), Unc-89 (Obscurin) (**R**) and Strn-Mlck (**U**). Images for the same protein were acquired using the same settings, and pseudo-coloured based on intensity. Note the close correlation between mRNA and protein expression dynamics. Time points are indicated by blue dots on the mRNA expression profile. Scale bars represent 20 µm.](elife-34058-fig2){#fig2}

A transcriptional transition after 30 hr APF {#s2-3}
--------------------------------------------

Hierarchical clustering of the core expression profiles from the 40 identified Mfuzz clusters defines eight temporally ordered groups ([Figure 3](#fig3){ref-type="fig"}) that show progressive expression dynamics as muscle development proceeds. A time-dependent shift in gene ontology (GO) term enrichments is apparent between the eight groups, reflecting the different stages of IFM development. GO-Elite analysis ([@bib92]) for gene set enrichment identified GO terms related to cell proliferation and development as enriched in the early clusters (such as the *twi* cluster 27 or the *kon* cluster 15), whereas terms related to actin filament dynamics are more enriched in the middle clusters (such as the βPS-Integrin cluster seven and the Talin cluster 25), reassuring that the clustering approach is valid ([Figure 3](#fig3){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Strikingly, the only two clusters that display a strong enrichment for genes important for sarcomere organisation are clusters 13 and 22, both of which are late up-regulated clusters ([Figure 3](#fig3){ref-type="fig"}). Members of both clusters just become detectable at 30 hr APF (Unc-89/Obscurin-GFP, Act88F-GFP, Mhc-GFP) or even later at 48 hr APF (Strn-Mlck-GFP, Mf-GFP). In all cases, we could confirm the strong up-regulation from 30 hr to 72 hr APF in the mRNA-Seq data at the protein level using GFP fusion proteins under endogenous control ([Figure 2P--U](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2J--P](#fig2s2){ref-type="fig"}) ([@bib63]). We additionally verified the late up-regulation of Flightin (Fln), a member of cluster 3, which is detectable at 72 hr but not at 30 hr APF ([Figure 2---figure supplement 2G--I](#fig2s2){ref-type="fig"}).

![Expression dynamics reveal a temporal ordering of biological processes during muscle morphogenesis.\
(**Top**) Heat map of Mfuzz cluster core expression profiles. Standard-normal count values for all genes with a membership value α \>0.8 were averaged to generate the core expression profile for each cluster. Mfuzz expression profiles fall into eight groups (coloured dendrogram leaves) based on hierarchical clustering of their temporal expression dynamics. Time points and Mfuzz clusters are labelled. Colour scale of standard-normal count values ranges from blue (stable/no expression) to red (high expression). (Bottom) GO Biological Process and user-defined gene set (marked with \*) enrichments calculated with GO-Elite. Note that proliferation, development and differentiation terms are enriched at early time points, while mitochondrial and sarcomere terms are enriched at late time points. A coloured box indicates a significant enrichment of a given term in the specified cluster (see [Supplementary file 2](#supp2){ref-type="supplementary-material"} for details).](elife-34058-fig3){#fig3}

At late stages of flight muscle development, mitochondrial density strongly increases ([@bib12]). Using GO-Elite, we found a strong enrichment for mitochondrial related pathways in four late up-regulated clusters, namely 3, 28, 39 as well as the sarcomere cluster 22 ([Figure 3](#fig3){ref-type="fig"}). By comparing the clusters to systematic functional data acquired at all stages of *Drosophila* muscle development ([@bib68]), we find enrichments in clusters throughout the time-course. Interestingly, genes highly expressed in flight muscle compared to other muscle types, identified as '*salm*-core genes' ([@bib75]), are also enriched in the late clusters, including the mitochondrial enriched clusters 3, 28, 39 and the sarcomere enriched cluster 22 ([Figure 3](#fig3){ref-type="fig"}). These data highlight the changes in biological process enrichments that parallel expression dynamics, with a particular transition happening during later stages of muscle development after 30 hr APF. This corresponds to a time period after immature myofibrils have been assembled, which thus far remained largely unexplored.

To examine the temporal expression dynamics in more detail, we performed a principle component analysis (PCA) of the mRNA-Seq time points and Mfuzz clusters and found that the major variance is developmental time, with a notable change after 30 hr APF ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). There are a large number of genes being up-regulated as well as down-regulated between 30 and 48 hr and between 48 and 72 hr APF, with major differences between the sets of genes expressed at early (16--30 hr APF) versus late (72--90 hr APF) stages of development ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Thus, we focused our attention on the transcriptional transition between 30 and 72 hr APF, which correlates with major growth of the flight muscle fibers ([Figure 1](#fig1){ref-type="fig"}).

![A major transition in gene expression after 30 hr APF.\
(**A**) DESeq2 principle components analysis (PCA) of all mRNA-Seq libraries. Each triangle represents a different biological replicate coloured by time point. Note that individual replicates for a given time point cluster together. PC1 divides early (≤48 hr APF) from late (≥72 hr) stages. (**B**) Stacked box plot of the number of significantly differentially expressed genes up-regulated (reds) or down-regulated (blues) between sequential time points with a p-value\<0.05 and a log~2~FC (fold change) of \>1 (dark), \>2 (medium) or \>5 (light). The large differences between myoblast to 16 hr APF reflect muscle specification. A second large shift in expression is evident between 30 and 72 hr APF. (**C**) Volcano plot illustrating the strong up-regulation of sarcomeric proteins (red) from 30 hr to 72 hr APF. Significantly up- or down-regulated genes are in blue (p-value\<0.05 and abs(log~2~FC)\>2). (**D**) Hierarchical clustering of log~2~ transformed DESeq2 normalized counts for all genes that are significantly up-regulated between 30 and 72 hr APF. Note that they are either strongly induced at 48 or 72 hr APF (from yellow to red), or only turned on at 48 or 72 hr APF (blue to yellow/red), suggesting a major transition in gene expression after 30 hr APF. Colour scale of log~2~ count values ranges from blue (not expressed) to red (highly expressed). (**E**) GO-Elite and user-defined gene set (marked with \*) enrichments in up- (red) and down- (blue) regulated genes from 30 hr to 72 hr APF. Note the strong enrichment of mitochondrial and sarcomere terms in the up- regulated genes. (**F**) Pie charts showing the proportion of genes belonging to an enriched Mfuzz cluster in the sets of genes either up- or down-regulated from 30 hr to 72 hr APF. Note that a large proportion of genes up-regulated 30 hr to 72 hr belong to cluster 22, as well as Mfuzz clusters enriched for sarcomere (yellow) or mitochondrial (green) terms.](elife-34058-fig4){#fig4}

A large number of genes are significantly up- or down-regulated from 30 hr to 72 hr APF, as visualized on a volcano plot displaying log~2~fold changes (FC) ([Figure 4C](#fig4){ref-type="fig"}), suggesting a major change in gene expression. In particular, many sarcomeric genes are strongly up-regulated. To identify fine details in expression dynamics, we took all genes significantly up-regulated between 30 and 72 hr APF and performed hierarchical clustering of their DESeq2 normalized counts values ([Figure 4D](#fig4){ref-type="fig"}). We noted that many genes are turned on from 30 hr to 72 hr APF, whereas others are already expressed at 30 hr and strongly increase their expression until 72 hr ([Figure 4D](#fig4){ref-type="fig"}), suggesting a transcriptional transition after 30 hr APF. Consistently, we found GO-terms of cell proliferation, cell cycle and Notch signalling down-regulated, whereas actin cytoskeleton, sarcomere, muscle function and mitochondrial related gene sets are strongly up-regulated from 30 hr to 72 hr APF ([Figure 4E](#fig4){ref-type="fig"}). Finally, the genes up-regulated from 30 hr to 72 hr APF are enriched for sarcomeric proteins and the '*salm* core genes' ([Figure 4---figure supplement 1C,D](#fig4s1){ref-type="fig"}), and the Mfuzz gene clusters with the most up-regulated members are the mitochondrial and both sarcomeric gene containing clusters 13 and 22 ([Figure 4F](#fig4){ref-type="fig"}). Together, these data suggest that in particular expression of the sarcomeric and mitochondrial genes is strongly induced after 30 hr APF.

Ordered phases during sarcomere morphogenesis {#s2-4}
---------------------------------------------

The strong up-regulation of sarcomeric gene expression after immature myofibrils have been assembled ([Figure 1](#fig1){ref-type="fig"}) ([@bib86]) caught our interest and prompted us to more closely investigate the later stages of myofibrillogenesis during which myofibers grow dramatically ([Figure 1](#fig1){ref-type="fig"}). We stained the myofibers with phalloidin to reveal myofibril morphology and with the titin isoform Kettin (an isoform of the *sallimus* gene) to label the developing Z-discs and systematically quantified sarcomere length and myofibril width (see Materials and methods) ([Figure 5A](#fig5){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). By measuring the total muscle fiber length, we calculated the total number of sarcomeres per myofibril at a given stage. We found that the sarcomere length and width remain relatively constant at about 2.0 and 0.5 µm, respectively until 48 hr APF ([Figure 5B,C](#fig5){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). However, the number of sarcomeres per myofibril dramatically increases from about 100 at 34 hr to about 230 at 48 hr APF. After 48 hr only a few more sarcomeres are added, resulting in about 270 sarcomeres per myofibril at 60 hr APF. This number remains constant until the fly ecloses ([Figure 5D](#fig5){ref-type="fig"}, [Supplementary file 3](#supp3){ref-type="supplementary-material"}). Moreover, by analysing fiber cross-sections we found that the growth of the individual myofibril diameter correlates with growth of the entire muscle fiber. Both fiber diameter and myofibril diameter remain constant from 30 hr to 48 hr APF. After 48 hr the myofibril diameter grows nearly 3-fold from 0.46 µm to 1.43 µm in adult flies ([Figure 5E--G](#fig5){ref-type="fig"}), while fiber cross-sectional area grows nearly 4-fold from 1,759 µm^2^ to 6,970 µm^2^. Strikingly, during the entire time period from 30 hr APF to adults, the total number of myofibrils per muscle fiber remains constant (about 2000 per muscle fiber, [Figure 5H](#fig5){ref-type="fig"}). Taken together, these quantitative data lead us to propose ordered but somewhat overlapping phases of sarcomere morphogenesis: (1) During the sarcomere assembly phase, about 100 immature sarcomeres self-assemble within each immature myofibril. (2) Many short sarcomeres are added to each myofibril increasing its length. (3) The short sarcomeres grow in length and thickness to reach the mature pseudo-crystalline pattern. No new myofibrils are built after the initial myofibril assembly phase.

![Sequential phases of sarcomere morphogenesis in flight muscles.\
(**A**) Scheme of hemi-thoraces at 34, 48, 60, 72, 80, 90 hr APF and 1 day adults (muscle in red, tendon in blue, sarcomeres in yellow) with indicated muscle fiber length. Myofibrils and sarcomeres at these time points were stained for phalloidin (F-actin, red) and Kettin (Z-disc, green). Scale bar represents 5 µm. (**B,C**) Tukey box and whisker plot of sarcomere length and myofibril width. Box extends from 25 to 75%, line marks median, whiskers extend to 25/75% plus 1.5 times the interquartile range. (**D**) Histogram of sarcomere number per myofibril. Error bars represent SD. Note the sarcomere assembly at 34 hr, followed by sarcomere addition until \~48 hr and sarcomere maturation after \~48 hr APF. (**E**) Cross-sections of the DLMs at 30, 48, 60, 72, 80, 90 hr APF and 1 day adult. Scale bar represents 5 µm. (**F,G**) Tukey box and whisker plot of myofibril diameter and myofiber cross-sectional area. Note the lack of growth in diameter or area from 30 hr to 48 hr. (**H**) Histogram of the number of myofibrils per myofiber. Error bars represent SD. Note that all myofibrils are already present at 30 hr APF. Tukey's multiple comparison p-value\<0.05\*,. 01\*\*,. 001\*\*\*, n.s. = not significant. N \> 10 for each individual time point. (**I**) Stills of live movies of DLMs at 30, 36, 42, 48, 60 and 72 hr APF. Scale bar represents 50 µm. For live movies see [Figure 5---video 1](#fig5video1){ref-type="video"}. Stills are a time 0.0 s image (magenta) overlaid with a time +0.65 s image (green), where a perfect overlap (white) shows no movement. (**J**) Quantification of spontaneous contraction events per fiber per 5 min, with single twitches in blue and double twitches in green. Fibers are first contractile at 30 hr APF, reach peak contractility at 48 hr and stop all spontaneous contraction shortly after 60 hr APF.\
10.7554/eLife.34058.013Figure 5---source data 1.This table includes calculation of the number of sarcomeres per myofibril in wild type flight muscles at the indicated stage.\
10.7554/eLife.34058.014Figure 5---source data 2.This table includes the sarcomere length in wild type flight muscles measured at the indicated stage.Note that image analysis is limited by pixel size and thus can result in the same number.\
10.7554/eLife.34058.015Figure 5---source data 3.This table includes the sarcomere/myofibril width in wild type flight muscles measured at the indicated stage.Note that image analysis is limited by pixel size and thus can result in the same number.\
10.7554/eLife.34058.016Figure 5---source data 4.This table includes the myofiber cross-sectional area measured in wild type flight muscle fibers or only fibers 3 and four at the indicated stage.\
10.7554/eLife.34058.017Figure 5---source data 5.This table includes the number of myofibrils per myofiber calculated for either all wild type flight muscle fibers or only fibers 3 and four at the indicated stage.\
10.7554/eLife.34058.018Figure 5---source data 6.This table includes the myofibril diameter measured in wild type flight muscles at the indicated stage.\
10.7554/eLife.34058.019Figure 5---source data 7.This table includes the muscle twitch events per wild-type fiber per 5 min recorded at the indicated stage.](elife-34058-fig5){#fig5}

We gained additional evidence to support this ordered myofibrillogenesis model on both the molecular and functional levels. First, the initial assembly versus the later sarcomere maturation complement the transition in gene expression we observe from 30 hr to 72 hr APF. Using members of the late induced Mfuzz clusters that contain sarcomeric components, we found that indeed a subset of sarcomeric proteins, such as Unc-89/Obscurin and Mhc, are already detectable in a periodic pattern on immature myofibrils at 30 hr. By contrast, other important components, including Fln, Myofilin (Mf) and Strn-Mlck, are only incorporated into myofibrils from 48 hr APF, showing high levels by 72 hr APF ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Second, to investigate muscle function, we used Talin-YPet as a muscle attachment marker and quantified the number of spontaneous muscle contractions in intact pupae (see Materials and methods). Interestingly, we found that immature myofibrils already start to spontaneously contract at 30 hr APF. These spontaneous contractions increase in strength and frequency until 48 hr APF, but then cease, producing no detectable spontaneous contractions at 72 hr APF ([Figure 5I,J](#fig5){ref-type="fig"}, [Figure 5---video 1](#fig5video1){ref-type="video"}). This demonstrates that during the sarcomere assembly phase, immature contractile myofibrils are generated, which then likely acquire stretch-sensitivity as the immature myofibrils mature and thus cease contracting.

Salm contributes to the transcriptional transition after 30 hr APF {#s2-5}
------------------------------------------------------------------

How does the transcriptional transition of the various sarcomeric components instruct myofibrillogenesis? As the identified sarcomeric clusters 13 and 22 are enriched for '*salm*-core genes' ([@bib75]) ([Figure 3](#fig3){ref-type="fig"}), we chose to investigate gene expression in developing *spalt-major* knock-down (*salmIR*) flight muscles compared to wild type ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). *salmIR* IFM shows a strong down-regulation in gene expression, notably of mRNAs coding for sarcomeric and mitochondrial components at 24 and 30 hr APF, and in particular at 72 hr APF ([Figure 6A--C](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A--D](#fig6s1){ref-type="fig"}). The genes down-regulated in *salmIR* IFM are enriched for GO terms associated with sarcomere assembly, flight behaviour and mitochondrial genes, as well as for the mitochondrial Mfuzz clusters 3, 28, 39 and the sarcomeric Mfuzz clusters 13 and 22 ([Figure 6---figure supplement 1E--G](#fig6s1){ref-type="fig"}). Interestingly, members of cluster 22, which is strongly enriched for sarcomeric and mitochondrial genes, are not only down-regulated at 72 hr APF in *salmIR* ([Figure 6B](#fig6){ref-type="fig"}) but are also less strongly induced from 30 hr to 72 hr APF in *salmIR* muscle compared to wild type ([Figure 6D](#fig6){ref-type="fig"}), suggesting that *salm* in addition to other factors is indeed required for the strong induction of sarcomeric protein expression after 30 hr APF.

![*salm* contributes to the transition in gene expression after 30 hr APF.\
(**A**) Volcano plot of mRNA-Seq comparison of wild-type (WT) versus *salmIR* IFMs at 72 hr APF. Note the significant down-regulation of genes in *salmIR*, especially sarcomeric protein coding genes (red). Significantly differentially expressed (DE) genes (abs(log~2~ FC)\>2, p\<0.05) are in blue. (**B**) Violin plot showing down-regulation of sarcomeric proteins (in red), mitochondrial proteins (in green) and members of Mfuzz cluster 22 (in yellow) in *salmIR* compared to wild type at 72 hr APF. Box plots indicate the median of the data as well as the first and third quartile in the box, outliers are the dots. (**C**) WT mRNA-Seq fold change values of all genes significantly DE from 30 hr to 72 hr APF are ordered from lowest to highest (black). The corresponding *salmIR* fold change is shown in yellow. Both sarcomeric (red) and mitochondrial protein coding genes (blue) are less strongly up- or down-regulated in *salmIR* across the 30 hr to 72 hr APF transition. Note that many genes in *salmIR* (yellow dots) are not as strongly induced or even repressed compared to WT (below and above the black WT line, respectively). (**D**) Violin plot comparing the log~2~FC over the 30 hr to 72 hr transition in WT (in black) and *salmIR* IFM (in magenta) for members of Mfuzz Cluster22. Box plots indicate the median of the data as well as the first and third quartile in the box, outliers are the dots. Note the significant decrease in induction to 72 hr APF in the *salmIR* sample. \*\*\*Student's t-test p-value\<0.0005. (**E--H**) *salm* is required for the induction of some but not all sarcomeric proteins. *Act88F \>\> salmIR* in the background of GFP-tagged Strn-Mlck-IsoR (**E**), Fln (**F**), Mhc (**G**) and Unc-89 (**H**). Quantitative changes in live GFP fluorescence at 90 hr APF were measured by quantitative confocal microscopy relative to standard fluorescent beads, revealing significant decreases in induction for Strn-Mlck, Fln and Mhc between wild type control (shown in yellow, *Act88F*-GAL4 crossed to *w^1118^*) and *Act88F \>\> salmIR* (shown in purple). Scale bar represents 5 µm. Error bars represent SEM, Student's t-test p-value\<0.05\*, 0.001\*\*\*, n.s. = not significant. N \> 10 for each individual sample. (**E'--H''**) Intensity-coded GFP fluorescence at 90 hr APF in confocal images of fixed myofibrils.\
10.7554/eLife.34058.025Figure 6---source data 1.This table includes the fiber divided by bead fluorescence intensity measurements for quantification of the indicated fosmid-GFP or UAS-GFP-Gma expression levels at the indicated stage.\
10.7554/eLife.34058.026Figure 6---source data 2.This table includes the fiber divided by bead fluorescence intensity measurements for various fosmid-GFPs in the *Act88F \>\> salmIR* or control *Act88F-Gal4 x w-* background at 90 hr APF.](elife-34058-fig6){#fig6}

Salm is expressed shortly after myoblast fusion and constitutive knock-down of *salm* with *Mef2*-GAL4 results in a major shift of muscle fiber fate ([@bib69]), which may indirectly influence transcription after 30 hr APF. Hence, we aimed to reduce Salm levels only later in development, to directly address its role during sarcomere maturation. To this end, we knocked-down *salm* with the flight muscle specific driver *Act88F*-GAL4, which is expressed from about 18 hr APF and requires *salm* activity for its expression ([@bib5]; [@bib75]). This strategy enabled us to reduce Salm protein levels at 24 hr APF resulting in undetectable Salm levels at 72 hr APF ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). To test if Salm contributes to the transcriptional boost of sarcomeric components after 30 hr APF, we performed quantitative imaging using unfixed living flight muscles expressing GFP fusion proteins under endogenous control. We used green fluorescent beads to normalise the GFP intensity between different samples, and could verify the induction of Mhc, Unc-89, Fln and Strn-Mlck on the protein level from 30 hr to 72 hr APF ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). While overall sarcomere morphology is not strongly affected in *Act88F \>\> salmIR* muscles, we found that the levels of Strn-Mlck, Fln and Mhc proteins are strongly reduced at 90 hr as compared to wild-type controls ([Figure 6D--H](#fig6){ref-type="fig"}). This suggests that *salm* indeed contributes to the transcriptional transition that boosts the expression of a number of sarcomeric proteins after 30 hr APF.

To investigate the consequences of late *salm* knock-down, we quantified the myofibril and sarcomere morphology from 48 hr onwards. The myofibrils display a fibrillar morphology, confirming that the early function of Salm to determine IFM fate was unaffected by our late knock-down. At 72 hr APF and more prominently at 90 hr APF and in adults, *Act88F \>\> salmIR* myofibrils showed actin accumulations at broadened Z-discs ([Figure 7A--H](#fig7){ref-type="fig"}), which are often a landmark of nemaline myopathies ([@bib70]; [@bib83]). The myofibril width was not significantly different in these myofibrils ([Figure 7I](#fig7){ref-type="fig"}). However, the sarcomeres of *Act88F \>\> salmIR* muscles displayed a strong defect in sarcomere length growth after 48 hr APF ([Figure 7J](#fig7){ref-type="fig"}, [Supplemental File 3](#supp3){ref-type="supplementary-material"}), with sarcomeres only obtaining a length of 2.8 µm in adult flies, demonstrating that Salm in addition to other factors is required for normal sarcomere maturation.

![*salm* is required for normal sarcomere maturation and function.\
(**A--H**) Myofibrils of *Act88F*-GAL4 / + (**A--D**) or *Act88F* \>\> *salmIR* (**E--H**). Note that *salmIR* DLM remains fibrillar and appears normal at 48 hr APF (**E**), but at 72 hr APF (**F**) 90 hr APF (**G**) and 2 day adult (**H**) Z-discs widen and show actin accumulations (arrowheads). (**I,J**) Tukey box and whisker plot of myofibril width (**I**) and sarcomere length (**J**) in *Act88F*-GAL4 /+ and *Act88F* \>\> *salmIR* (red). Tukey's multiple comparison p-value\<0.001\*\*\*. N \> 10 for each individual time point. Scale bars represent 5 µm. (**K--O**) Stills from live movies of developing DLMs at 48 and 72 hr APF in *Act88F*-GAL4 / + (**K, M**) and *Act88F* \>\> *salmIR* (**L, N**). Scale bar represents 50 µm. Coloured as in [Figure 5](#fig5){ref-type="fig"}. (**O**) Quantification of spontaneous contraction events per fiber per 5 min, with single twitches in blue and double twitches in green. Error bars represent SEM. *salmIR* fibers continue spontaneously contracting at 72 hr APF.\
10.7554/eLife.34058.029Figure 7---source data 1.This table includes the muscle twitch events per *Act88F \>\> salmIR* fiber per 5 min and the respective controls recorded at the indicated stage.\
10.7554/eLife.34058.030Figure 7---source data 2.This table includes the sarcomere length measured in *Act88F \>\> salmIR* flight muscles and the respective controls at the indicated stage.Note that image analysis is limited by pixel size and thus can result in the same number.\
10.7554/eLife.34058.031Figure 7---source data 3.This tables includes the sarcomere/myofibril width measured in *Act88F \>\> salmIR* flight muscles and the respective controls at the indicated stage.Note that image analysis is limited by pixel size and thus can result in the same number.](elife-34058-fig7){#fig7}

Salm function contributes to gain of stretch-activation during sarcomere maturation {#s2-6}
-----------------------------------------------------------------------------------

Given the defects in sarcomere length and sarcomere gene expression in *Act88F \>\> salmIR* muscles, we explored the function of these abnormal muscle fibers. As expected, *Act88F \>\> salmIR* flies are flightless ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}) and we observed rupturing of the adult muscle fibers within 1d after eclosion ([Figure 7---figure supplement 1B--G](#fig7s1){ref-type="fig"}), demonstrating the importance of proper sarcomere maturation to prevent muscle atrophy. Based on our finding that spontaneous flight muscle contractions stop by 72 hr APF, we hypothesized that if Salm truly regulates sarcomere maturation, we may see spontaneous contraction defects during development. At 48 hr APF, *Act88F \>\> salmIR* fibers twitch, but less often than and without the double twitches observed in control fibers ([Figure 7K,L,O](#fig7){ref-type="fig"}; [Figure 7---video 1](#fig7video1){ref-type="video"}). Strikingly, at 72 hr APF *salmIR* fibers fail to stop contracting and moreover show frequent and uncoordinated spontaneous contractions in which different myofibril bundles of the same fiber twitch at different times ([Figure 7M--O](#fig7){ref-type="fig"}, [Figure 7---video 2](#fig7video2){ref-type="video"}), demonstrating that sarcomere maturation is indeed disrupted, with the likely consequence that myofibrils fail to acquire normal stretch-activation sensitivity.

To directly test the function of a sarcomeric component during the sarcomere maturation phase, we investigated the role of the prominently induced Salm target Strn-Mlck. Strn-Mlck is only expressed after 30 hr APF and is largely incorporated during sarcomere maturation ([Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}, [Figure 6---figure supplement 3E](#fig6s1){ref-type="fig"}), and thus is also a bone-fide example of a gene regulated during the transcriptional transition. In *Strn-Mlck* mutants, sarcomere and myofibril morphology, including myofibril width, is initially normal. However, at 80 hr APF the sarcomeres overgrow, consistently reaching lengths of more than 3.5 µm and resulting in slightly longer muscle fibers at 80 hr APF ([Figure 8](#fig8){ref-type="fig"}). After overgrowing, sarcomeres appear to hyper-contract resulting in short, thick sarcomeres in 1-day-old adults ([Figure 8E,J,K,L](#fig8){ref-type="fig"}). Like *Act88F \>\> salmIR* flies, *Strn-Mlck* mutant adults are flightless ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}) and display ruptured fibers during the first days of life ([Figure 7---figure supplement 1K--M](#fig7s1){ref-type="fig"}) ([@bib75]). Together, these data demonstrate that sarcomere maturation must be precisely controlled at the transcriptional level to enable the precise growth of sarcomeres to their final mature size. This ensures the lifelong function of the contractile apparatus of muscle fibers.

![Strn-Mlck contributes to sarcomere length regulation during sarcomere maturation.\
(**A--J**) Wild type (**A--E**) and *Strn^M102893^* mutant (**F--J**) sarcomere development at 48, 72, 80, 90 hr APF and 1 day adult. (**K--N**) Tukey box and whisker plot of myofibril width (**K**) and sarcomere length (**L**) in wild type and *Strn^M102893^* mutant (red). Tukey's multiple comparison p-value\<0.001\*\*\*. N \> 10 for each individual time point. Histogram of fiber length (**M**) and number of sarcomeres per myofibril (**N**). Error bars represent SEM. Tukey's multiple comparison p-value\<0.01\*\*, N \> 10 for each individual time point. Note that a normal number of sarcomeres are formed in *Strn^M102893^* mutants, but they grow too long at 80 hr APF and hyper-contract in 1 day adult.\
10.7554/eLife.34058.035Figure 8---source data 1.This table includes the numbers of sarcomeres calculated per *strn-mlck* mutant myofibril and the respective control at the indicated stage.\
10.7554/eLife.34058.036Figure 8---source data 2.This table includes the length measurements of the indirect flight muscle fibers at the indicated stage for *strn-mlck* mutants and wild-type controls.\
10.7554/eLife.34058.037Figure 8---source data 3.This table includes the calculated numbers of sarcomeres per myofibril at the indicated stage for *strn-mlck* mutants.Note that image analysis is limited by pixel size and thus can result in the same number.\
10.7554/eLife.34058.038Figure 8---source data 4.This table includes the sarcomere length measured in strn-mlck mutant flight muscles at the indicated stage.Note that image analysis is limited by pixel size and thus can result in the same number.](elife-34058-fig8){#fig8}

Discussion {#s3}
==========

A developmental muscle transcriptomics resource {#s3-1}
-----------------------------------------------

In this study, we generated a systematic developmental transcriptomics resource from *Drosophila* flight muscle. The resource quantifies the transcriptional dynamics across all the major stages of muscle development over five days, starting with stem cell-like myoblasts and attaching myotubes to fully differentiated, stretch-activatable muscle fibers. We have specifically focused on the transcriptional regulation of sarcomere and myofibril morphogenesis; however, the data we provide cover all other expected dynamics, such as mitochondrial biogenesis, T-tubule morphogenesis, neuromuscular junction formation, tracheal invagination, *etc*. Thus, together with the available systematic functional data of *Drosophila* muscle development ([@bib68]), our data should be a versatile resource for the muscle community. It nicely complements existing systematic data from vertebrate muscle, which thus far are largely restricted to postnatal stages ([@bib4]; [@bib15]; [@bib35]; [@bib96]). Furthermore, *Drosophila* flight muscle contains a single muscle fiber type, in contrast to the mixed fiber types found in mammals ([@bib64]; [@bib76]). Hence, in this model the transcriptional dynamics of a single fiber type muscle can be followed with unprecedented precision.

A transcriptional transition correlating with ordered sarcomere morphogenesis {#s3-2}
-----------------------------------------------------------------------------

Earlier work has shown that the flight muscle myotubes first attach to tendon cells and then build-up mechanical tension. This tension triggers the simultaneous assembly of immature myofibrils, converting the myotube to an early myofiber ([@bib86]). This suggested a tension-driven self-organisation mechanism of myofibrillogenesis ([@bib38]). Here we discovered that myofibrillogenesis is not only regulated mechanically, but to a large extent also transcriptionally. This enabled us to extend our model for ordered myofibrillogenesis also to later developmental stages and to define three sequential although somewhat overlapping phases ([Figure 9](#fig9){ref-type="fig"}). During the sarcomere self-assembly phase at about 30 hr APF, a large number of genes coding for sarcomeric proteins, including Mhc, Act88F and Unc-89/Obscurin, become up-regulated to enable the self-organization of short, immature sarcomeres within thin, immature myofibrils. Strikingly, all of the about 2000 myofibrils assemble during this phase.

![Model for ordered sarcomere morphogenesis.\
Phase 1 - Sarcomere assembly: Sarcomeric proteins are expressed at low levels, enabling the self-assembly of immature sarcomeres and myofibrils at around 30 hr APF. Each of the 2000 myofibrils contains about 80 immature sarcomeres. Phase 2 - Sarcomere addition: Sarcomere protein expression increases and each immature myofibril incorporates many new sarcomeres until about 48 hr APF. These immature sarcomeres contract spontaneously. Phase 3 - Sarcomere maturation: After 48 hr APF, sarcomere protein expression increases even more, including flight muscle specific proteins/isoforms, and all sarcomeres strongly grow in width and length. This enables the flight muscle to gain stretch-activation. Muscles are shown in red, tendons in blue. Structural proteins are illustrated as cartoons and are not drawn to scale. Induction of Actin, Mhc, Myofilin, Flightin, Strn-Mlck and Unc-89/Obscurin is shown here, expression of αActinin, Projectin and Kettin/Sallimus was shown by others ([@bib6]; [@bib8]; [@bib31]; [@bib51]; [@bib86]).](elife-34058-fig9){#fig9}

This is followed by a sarcomere addition phase during which a transcriptional transition is initiated and the expression of the sarcomeric proteins increases. Concomitantly, the muscle fibers grow in length by addition of new sarcomeres to all the immature myofibrils, increasing the sarcomere number from about 80 to 230 per fibril at 48 hr APF. These sarcomeres are contractile, but remain short and thin ([Figure 9](#fig9){ref-type="fig"}).

After the transcriptional transition, myofibrillogenesis enters the final sarcomere maturation phase. Proteins present in immature myofibrils like Mhc, Act88F and Unc-89/Obscurin are expressed to even higher levels, and additional, often flight-muscle specific proteins like Mf, Fln and the titin-related isoform Strn-Mlck, begin to be expressed at high levels and are incorporated into the maturing sarcomeres. This facilitates a dramatic growth of all immature sarcomeres in length and particularly in diameter with all 2000 myofibrils reaching a pseudo-crystalline regularity within about two days of development ([Figure 9](#fig9){ref-type="fig"}). Importantly, these matured sarcomeres no longer contract spontaneously, likely because they acquired the stretch-activated mechanism of contraction described for mature *Drosophila* flight muscles ([@bib7]; [@bib30]).

Our ordered sarcomere morphogenesis model is strongly supported by the observation that the number of myofibrils remains largely constant during the entire sarcomere morphogenesis period, suggesting that in flight muscles no new myofibrils are added after the initial assembly of immature myofibrils at about 30 hr APF. As all sarcomeres are present shortly after 48 hr APF, they all need to mature simultaneously to achieve their final pseudo-crystalline regularity.

Our model is further supported by previous studies. We and others found that immature myofibrils have a width of about 0.5 µm ([@bib86]), which corresponds to about four thick filaments across each myofibril at the EM level at 42 hr APF (at 22°C) ([@bib56]). This 'core' myofibril structure built until 48 hr APF, when most sarcomeres have formed, is expanded dramatically after 48 hr APF, reaching a mature width of 1.5 µm, corresponding to about 35 thick filaments across each myofibril at the EM-level ([@bib56]). Recent data showed that the 'core' myofibril structure built until 48 hr APF contains already highly ordered actin filaments, which gain even higher order to reach their pseudo-crystalline regularity at 90 hr APF ([@bib44]). In total, each adult myofibril contains around 800 thick filaments per sarcomere ([@bib23]). The 'core' myofibril structure was also revealed by the preferential recruitment of over-expressed actin isoforms ([@bib59]) and more importantly, by selective incorporation of a particular Mhc isoform that is only expressed at mid-stages of flight muscle development ([@bib52]). This Mhc isoform expression switch coincides with the global transition in sarcomeric gene expression between the sarcomere assembly and the sarcomere maturation phases that we defined here. It also fits with the recent discovery that the formin family member Fhos is selectively required for actin filament elongation and recruitment of new actin filaments and thus myofibril diameter growth after 48 hr APF ([@bib71]). Expression of Fhos is also induced after 30 hr APF. Fhos is a member of Mfuzz Cluster 28, another strongly induced cluster, underscoring the general relevance of the transcriptional transition for ordered sarcomerogenesis.

Regulated active sarcomere contractions {#s3-3}
---------------------------------------

Mature indirect flight muscles employ a stretch-activated mechanism of muscle contraction, thus Ca^2+^ is not sufficient to trigger muscle contractions without additional mechanical stretch ([@bib7]; [@bib30]). This is different to cross-striated body muscles of flies or mammals that contract synchronously with Ca^2+^ influx. Hence, it is intriguing that immature flight muscle myofibrils do in fact contract spontaneously, with the contraction frequencies and intensities increasing until 48 hr APF. It was recently proposed in *Drosophila* cross-striated abdominal muscles and in developing cross-striated zebrafish muscles that spontaneous contractions are important for the proper formation of the cross-striated pattern ([@bib47]; [@bib85]). A similar role for contractions was found in C2C12 cells by stimulating the contractions optogenetically ([@bib2]). This shows that spontaneous contractions are a necessary general feature for the assembly of cross-striated muscle fibers across species.

However, flight muscles are not cross-striated in the classical sense, but have a fibrillar organisation in which each myofibril remains isolated and is not aligned with its neighbouring myofibrils ([Figure 5](#fig5){ref-type="fig"}) ([@bib30]; [@bib69]). We can only speculate about the mechanism that prevents alignment of the myofibrils in the flight muscles, but it is likely related to their stretch-activated contraction mechanism. This mechanism prevents spontaneous twitching due to increased Ca^2+^ levels, because it additionally requires mechanical activation that can only occur during flight in the adult. Thus, flight muscle sarcomeres not only grow and mature their sarcomere structure, they also gain their stretch-activatability.

Continuous maintenance of muscle type-specific fate {#s3-4}
---------------------------------------------------

We identified an important transition in gene expression between the early sarcomere assembly and the late sarcomere maturation phases. Similar large scale transcriptome changes have also been observed during postnatal stages of mouse ([@bib4]), chicken ([@bib96]) and pig ([@bib95]) skeletal muscle development or during regeneration after injury in fish ([@bib48]) and mouse muscles ([@bib84]), indicating that muscle maturation generally correlates with large scale transcriptional changes.

It is well established that general myogenic transcription factors, in particular Mef2, are continuously required in muscles for their normal differentiation ([@bib60]; [@bib72]). Mef2 regulates a suit of sarcomeric proteins in fly, fish and mouse muscle important for correct sarcomere assembly and maturation ([@bib29]; [@bib32]; [@bib54]; [@bib77]). In *Drosophila*, Mef2 cooperates with tissue-specific factors, such as CF2, to induce and fine-tune expression of structural genes ([@bib23]; [@bib24]; [@bib79]). General transcriptional regulators, such as E2F, further contribute to high levels of muscle gene expression during myofibrillogenesis, in part through regulation of Mef2 itself ([@bib93]). However, it is less clear if muscle type-specific identity genes are continuously required to execute muscle type-specific fate. Spalt major (Salm) is expressed after myoblast fusion in flight muscle myotubes and is required for all flight muscle type-specific gene expression: in its absence the fibrillar flight muscle is converted to tubular cross-striated muscle ([@bib69]; [@bib75]). Here we demonstrated that Salm is continuously required for correct sarcomere morphogenesis, as late *salm* knock-down leads to defects in sarcomere growth during the late sarcomere maturation phase, causing severe muscle atrophy in adults. It might do so by modifying the cooperation between Mef2 and E2F or by changing chromatin states, as vertebrate spalt homologs are recently discussed as epigenetic regulators ([@bib91]; [@bib94]). However, Salm cannot be solely responsible for the transcriptional transition after 30 hr APF, as the transition still partially occurs in its absence.

Ordered sarcomere morphogenesis -- a general mechanism? {#s3-5}
-------------------------------------------------------

Here we defined ordered phases of sarcomere morphogenesis in *Drosophila* flight muscles. Is this a general concept for sarcomere morphogenesis? Reviewing the literature, one finds that in other *Drosophila* muscle types which display a tubular cross-striated myofibril organisation, such as the fly abdominal muscles, the striated sarcomeres also first assemble and then grow in length ([@bib53]; [@bib85]), suggesting a conserved mechanism. In developing zebrafish skeletal muscles, young myofibers present in younger somites show a short sarcomere length of about 1.2 µm, which increases to about 2.3 µm when somites and muscle fibers mature ([@bib61]; [@bib62]). Interestingly, sarcomere length as well as thick filament length increase simultaneously during fish muscle maturation, indicating that as in flight muscles, the length of all sarcomeres in one large muscle fiber is homogenous at a given time ([@bib62]). Similar results were obtained in mouse cardiomyocytes measuring myosin filament length at young (two somite) and older (13 somite) stages ([@bib16]) and even in human cardiomyocytes, in which myofibrils increase nearly threefold in width and become notably more organized and contractile from 52 to 127 days of gestation ([@bib55]). These data suggest that sarcomeres generally may go through a series of ordered but overlapping developmental phases.

Interestingly, these changes in sarcomere morphology correlate with a switch in myosin heavy chain isoform expression changing from embryonic to neonatal to adult during skeletal muscle development ([@bib65]). Importantly, mutations in embryonic myosin (MYH3 in humans) result in severe congenital disorders characterised by multiple facial and limb contractures ([@bib80]). As a similar ordered expression of myosin isoforms is also found during muscle regeneration after injury in adults ([@bib11]; [@bib65]), we hypothesize that our sequential sarcomere morphogenesis model may also be applicable to vertebrate skeletal and possibly heart muscles. It will be a future challenge to identify possible feedback mechanisms that indicate the successful end of the sarcomere assembly phase or a possible re-entry into the sarcomere assembly phase during muscle regeneration or exercise induced muscle fiber growth. It is enticing to speculate that the assembling cytoskeleton itself would measure its assembly status and provide a mechanical feedback signal to modify the activity of muscle-specific transcription factors.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation                     Source or reference          Identifiers                                                    Additional information
  or resource                                                                                                                                           
  ------------------------- ------------------------------- ---------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------
  Gene\                     spalt major; salm               NA                           FLYB:FBgn0261648                                               
  (*Drosophila*\                                                                                                                                        
  *melanogaster*)                                                                                                                                       

  Gene\                     Stretchin-Mlck;\                NA                           FLYB:FBgn0265045                                               
  (*D. melanogaster*)       Strn-Mlck                                                                                                                   

  Genetic reagent\          w\[1118\]                       Bloomington                  BDSC:3605;\                                                    
  (*D. melanogaster*)                                                                    FLYB:FBst0003605;\                                             
                                                                                         RRID:[BDSC_3605](https://scicrunch.org/resolver/BDSC_3605)     

  Genetic reagent\          salmIR                          PMID: 22094701               VDRC:13302;\                                                   Flybase symbol: VDRC:v13302
  (*D. melanogaster*)                                                                    FLYB:FBst0450930                                               

  Genetic reagent\          KK101052                        PMID: 17625558               VDRC:101052                                                    
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Act88F-GAL4                     PMID: 22008792                                                                              Source: Richard Cripps
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Strn-Mlck-MiMIC                 Bloomington                  FLYB:FBal0264439                                               Flybase symbol:Strn-MlckMI02893
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Strn-Mlck-IR                    PMID: 21460824               BDSC:31891;\                                                   Flybase symbol:P{TRiP.JF02170}attP2
  (*D. melanogaster*)                                                                    FLYB:FBti0130299;\                                             
                                                                                         RRID:[BDSC_31891](https://scicrunch.org/resolver/BDSC_31891)   

  Genetic reagent\          Strn-Mlck-GFP,\                 PMID: 25532219                                                                              Symbol: Strn4;
  (*D. melanogaster*)       Isoform R                                                                                                                   

  Genetic reagent\          Mhc-GFP                         PMID: 26896675               VDRC:318471                                                    Symbol: fTRG500;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Mf-GFP                          PMID: 26896675               VDRC:318132                                                    Symbol: fTRG501;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          rhea-GFP                        PMID: 26896675               VDRC:318486                                                    Symbol: fTRG587;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Fln-GFP                         PMID: 26896675               VDRC:318238                                                    Symbol: fTRG876;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          mys-GFP                         PMID: 26896675               VDRC:318285                                                    Symbol: fTRG932;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          βTub60D-GFP                     PMID: 26896675               VDRC:318309                                                    Symbol: fTRG958;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          unc-89-GFP                      PMID: 26896675               VDRC:318326                                                    Symbol: fTRG1046;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Act88F-GFP                      PMID: 26896675               VDRC:318362                                                    Symbol:fTRG10028;
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Him-nuc-eGFP                    PMID: 19324085                                                                              Source: Michael V. Taylor
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Him-GAL4                        this paper                                                                                  
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          UAS-BBM                         PMID: 22446736                                                                              
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Him-GFP-Gma                     this paper                                                                                  
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          rhea-YPet                       this paper                                                                                  
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          kon-GFP                         this paper                                                                                  
  (*D. melanogaster*)                                                                                                                                   

  Genetic reagent\          Mef2-GAL4                       Bloomington                  BDSC:27390;\                                                   
  (*D. melanogaster*)                                                                    RRID:[BDSC_27390](https://scicrunch.org/resolver/BDSC_27390)   

  Genetic reagent\          UAS-GFP-Gma                     PMID: 12324971                                                                              Source:Don Kiehart; Description
  (*D. melanogaster*)                                                                                                                                   

  Antibody                  guinea pig anti-Shot            PMID: 9832554                                                                               (1:500); Source: Talila Volk

  Antibody                  rat anti-Kettin\                Babraham Bioscience\         Babraham:\                                                     (1:50)
                            (MAC155/Klg16)                  Technologies                 MAC_155(P6689)                                                 

  Antibody                  rabbit anti-GFP (ab290)         Abcam                        Abcam:ab290                                                    (1:1000)

  Antibody                  rat anti-Bruno                  PMID: 12591598                                                                              (1:500); Source: Anne Ephrussi

  Antibody                  rabbit anti-Salm                PMID: 7905822                                                                               (1:50); Source: Reinhard Schuh

  Antibody                  mouse anti-βPS-\                Developmental Studies\       DSHB:CF.6G11                                                   (1:500)
                            integrin\                       Hybridoma Bank                                                                              
                            (CF.6G11)                                                                                                                   

  Antibody                  rabbit anti-Twi                 PMID: 2688897                                                                               (1:1000); Source: Siegfried Roth

  Antibody                  rabbit anti-Fln                 PMID: 11134077                                                                              (1:50); Source: Jim Vigoreaux

  Commercial\               fluorescent beads               ThermoFisher\                                                                               OrderID: InSpeckTM Green Kit I-7219
  assay or kit                                              (Molecular Probes)                                                                          

  Commercial\               Dynabeads                       Invitrogen                                                                                  OrderID: \#610.06
  assay or kit                                                                                                                                          

  Commercial\               Superscript III First-Strand\   Invitrogen                                                                                  OrderID: \#18080--051
  assay or kit              Synthesis System                                                                                                            

  Chemical\                 Fluoroshield with DAPI          Sigma                                                                                       OrderID: \#F6057
  compound, drug                                                                                                                                        

  Chemical\                 Vectashield with DAPI           Biozol                                                                                      OrderID: VEC-H-1200
  compound, drug                                                                                                                                        

  Chemical\                 Tissue-Tek O.C.T.               Weckert Labotechnik                                                                         OrderID: 4583; Sakura Finetek
  compound, drug                                                                                                                                        

  Chemical\                 TriPure reagent                 Roche                                                                                       OrderID: \#11667157001
  compound, drug                                                                                                                                        

  Software, algorithm       Fiji (Image J)                  PMID: 22743772                                                                              

  Software, algorithm       MyofibrilJ                      this paper                   1dbb0d4                                                        Source: <https://imagej.net/MyofibrilJ>

  Software, algorithm       STAR                            PMID: 23104886                                                                              

  Software, algorithm       SAMtools                        PMID: 19505943                                                                              

  Software, algorithm       featureCounts                   PMID: 24227677                                                                              

  Software, algorithm       DESeq2                          PMID: 25516281                                                                              

  Software, algorithm       R                               R Project for Statistical\   RRID:[SCR_001905](https://scicrunch.org/resolver/SCR_001905)   
                                                            Computing                                                                                   

  Software, algorithm       ComplexHeatmap                  PMID: 27207943                                                                              

  Software, algorithm       corrplot                        GitHub                                                                                      Source: <https://github.com/taiyun/corrplot>

  Software, algorithm       VennDiagram                     PMID: 21269502                                                                              

  Software, algorithm       plyr                            DOI: 10.18637/jss.v040.i01                                                                  

  Software, algorithm       reshape2                        DOI: 10.18637/jss.v021.i12                                                                  

  Software, algorithm       ggplot2                         ISBN:978-0-387-98140-6                                                                      

  Software, algorithm       RColorBrewer                    Author: Erich Neuwirth;                                                                     Source: <https://cran.r-project.org/web/packages/RColorBrewer/index.html>

  Software, algorithm       Mfuzz                           PMID: 16078370                                                                              

  Software, algorithm       GO-Elite                        PMID: 22743224                                                                              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly strains {#s4-1}
-----------

Fly stocks were maintained using standard culture conditions. Characterization of normal IFM sarcomere and fiber growth was performed in *w^1118^* grown at 27°C. *salm* RNAi was performed with previously characterized GD3029 (referred to as *salmIR)* and KK181052 ([@bib69]) from VDRC (<http://stockcenter.vdrc.at>) ([@bib13]) at 25°C using *Act88F*-GAL4 to induce knock-down after 24 hr APF. *Act88F*-GAL4 x *w^1118^* served as control. The *Strn-Mlck-MiMIC* insertion MI02893 into IFM-specific IsoR (Bloomington stock 37038) and TRiP hairpin JF02170 were obtained from Bloomington ([@bib50]). The *salm-*EGFP line was used to sort wing discs ([@bib46]). Tagged genomic fosmid reporter fly lines include *strn4* (*Strn-Mlck-GFP*, Isoform R) ([@bib75]), fTRG500 (*Mhc-GFP*, Isoforms K, L, M), fTRG501 (*Mf-GFP*, Isoforms A, G, N), fTRG587 (*Rhea-GFP*, Isoforms B, E, F, G), fTRG876 (*Fln-GFP*), fTRG932 (*mys-GFP*), fTRG958 (*βTub60D-GFP*), fTRG1046 (*unc-89-GFP*), and fTRG10028 (*Act88F-GFP*) ([@bib63]).

To label myoblasts, we utilized the enhancer for *Holes-in-muscle* (*Him*), which is expressed in dividing myoblasts and promotes the progenitor fate. *Him-nuc-eGFP* flies were a gift of M. Taylor ([@bib73]). *Him*-GAL4 flies were created by cloning an EcoRI to SacII fragment of the *Him* enhancer ([@bib42]) upstream of GAL4 into pStinger. UAS-BBM (UAS-palmCherry) ([@bib21]) was driven with *Him*-GAL4 to label myoblasts. *Him*-GFP-Gma flies were created by PCR amplifying GFP-Gma with AscI and PacI overhangs and then cloning downstream of the Him enhancer in pStinger to generate a gypsy insulator-*Him^enh^*-Gma-GFP-SV40-gypsy insulator cassette.

The *rhea-YPet* line used to label muscle ends for live imaging of twitch events was generated by CRISPR-mediated gene editing at the endogenous locus (S.B.L and F.S., details will be published elsewhere). The *kon-GFP* line was generated by inserting GFP into the *kon* locus after its transmembrane domain using the genomic fosmid FlyFos021621, which was integrated using Φ-C31 into VK00033 (I. Ferreira and F.S., details will be published elsewhere).

Flight tests {#s4-2}
------------

Flight tests were performed as previously described ([@bib68]). *Act88F*-GAL4 crosses were kept at 25°C, as higher temperatures negatively impacted flight ability, because of the very high GAL4 expression levels in this strain. Adult males were collected on CO~2~ and recovered at least 24 hr at 25°C before testing. Flies were introduced into the top of a 1 m long cylinder divided into five zones. Those that landed in the top two zones were considered 'normal fliers', those in the next two zones 'weak fliers' and those that fell to the bottom of the cylinder 'flightless'.

Immuno-staining {#s4-3}
---------------

Wing-discs were dissected from 3^rd^ instar wandering larvae in 1x PBS and fixed in 4% PFA in PBS-T. Discs were stained as described below for anti-GFP. Adult and pupal flight muscles were dissected and stained as previously described ([@bib87]). Briefly, early pupae (16--60 hr APF) were freed from the pupal case, fixed for 20 min. in 4% PFA in relaxing solution and washed in 0.5% PBS-Triton-X100 (PBS-T). 72 hr APF and older samples were cut sagittally with a microtome blade. All samples were blocked for at least 1 hr at RT in 5% normal goat serum in PBS-T and stained with primary antibodies overnight at 4°C. Primary antibodies include: guinea pig anti-Shot 1:500 (gift of T. Volk), rat anti-Kettin 1:50 (MAC155/Klg16, Babraham Institute), rabbit anti-GFP 1:1000 (ab290, Abcam), rat anti-Bruno 1:500 ([@bib20]), rabbit anti-Salm 1:50 ([@bib34]), mouse anti-βPS-integrin 1:500 (CF.6G11, DSHB), rabbit anti-Twi 1:1000 (gift of Siegfried Roth) and rabbit anti-Fln 1:50 ([@bib57]) (gift of Jim Vigoreaux). Samples were washed three times in 0.5% PBS-T and incubated overnight at 4°C with secondary conjugated antibodies (1:500) from Invitrogen (Molecular Probes) including: Alexa488 goat anti-guinea pig IgG, Alexa488 donkey anti-rat IgG, Alexa488 goat anti-mouse IgG, Alexa488 goat anti-rabbit IgG, rhodamine-phalloidin, Alexa568 goat anti-rabbit IgG and Alexa633 goat anti-mouse IgG. Samples were washed three times in 0.5% PBS-T and mounted in Vectashield containing DAPI.

Cryosections {#s4-4}
------------

Head, wings and abdomen were removed from one day old *w^1118^* flies and thoraxes were fixed overnight at 4°C in 4% PFA. For 30--90 hr APF samples, pupae were freed from the pupal case, poked 3--5 times with an insect pin in the abdomen and fixed overnight at 4°C in 4% PFA. Thoraxes or pupae were then sunk in 30% sucrose in 0.5% PBS-T overnight at 4°C on a nutator. Thoraxes or pupae were embedded in Tissue-Tek O.C.T. (Sakura Finetek) in plastic moulds (\#4566, Sakura Finetek) and frozen on dry ice. Blocks were sectioned at 30 µm on a cryostat (Microm vacutome). Sections were collected on glass slides coated with 1% gelatin +0.44 μM chromium potassium sulfate dodecahydrate to facilitate tissue adherence. Slides were post-fixed for 1 min. in 4% PFA in 0.5% PBS-T at RT, washed in 0.5% PBS-T, incubated with rhodamine-phalloidin for 2 hr at RT, washed three times in 0.5% PBS-T and mounted in Fluoroshield with DAPI (\#F6057, Sigma).

Microscopy and image analysis {#s4-5}
-----------------------------

Images were acquired with a Zeiss LSM 780 confocal microscope equipped with an α Plan-APOCHROMAT 100x oil immersion objective lens (NA 1.46). To compare if indicator protein expression replicates the mRNA-Seq expression dynamics, we imaged three time points from each expression profile with the same confocal settings. Laser gain and pinhole settings were set on the brightest sample and reused on remaining time points in the same imaging session. All samples were additionally stained with the same antibody mix on the same day and if possible in the same tube. Images were processed with Fiji ([@bib66]) and Photoshop, and displayed using the 'Fire' look-up table.

Fiber length and fiber cross-sectional area were measured with freehand drawing tools in Fiji based on rhodamine-phalloidin staining. Sarcomere length, myofibril width, and myofibril diameter were measured automatically using a custom Fiji plug-in, MyofibrilJ, available from <https://imagej.net/MyofibrilJ> and code from <https://github.com/giocard/MyofibrilJ> ([@bib9]; copy archived at <https://github.com/elifesciences-publications/MyofibrilJ>). All measurements are based on rhodamine-phalloidin staining, except 34 hr APF sarcomere lengths, which are based on both rhodamine-phalloidin and Unc-89-GFP staining. 'Sarcomeres per fibril' was calculated as average individual fiber length divided by sarcomere length for fiber 3 or 4. 'Fibrils per fiber' was calculated as average number of fibrils per unit area multiplied by individual fiber cross sectional area.

For determining myofibril diameter, samples were imaged using a 3x optical zoom (50 nm pixel size). At least 20 cross-section images from different fibers for \>10 flies were acquired for each time point. The number of fibrils per section and fibril diameter were determined with the tool 'analyze myofibrils crosswise' from MyofibrilJ (<https://imagej.net/MyofibrilJ>). In this tool, an initial estimate of the diameter is obtained by finding the first minimum in the radial average profile of the autocorrelation ([@bib27]) of the image. This estimate is used to calibrate the optimal crop area around all the cross-sections in the image, their position previously detected by finding the local intensity peaks. All of the detected cross-sections are then combined to obtain a noise-free average representation of the fibril section. Finally, the diameter is calculated by examining the radial profile of the average and measuring the full width where the intensity is 26% of the maximum range.

For determining sarcomere length and myofibril width, for each experiment between 10 and 25 images were acquired from more than 10 individual flies. From each image, nine non-overlapping regions of interest were selected, which were rotated to orient fibrils horizontally, when necessary. The tool 'analyze myofibrils lengthwise' from MyofibrilJ reports the sarcomere length (indicated as repeat) and myofibril width (indicated as thickness). Because of the periodic nature of sarcomere organization, their length is estimated by means of Fourier analysis, identifying the position of the peaks on the horizontal axis of the Fourier transformed imaged. Quality of the estimate was evaluated by visual inspection of the Fourier transformed image, overlaid with the peaks detected, as generated by the plug-in. Myofibrils width is estimated from the position of the first minimum in the vertical intensity profile of the autocorrelation of the image.

Live imaging of developmental spontaneous contractions was performed on a Leica SP5 confocal microscope. Prior to imaging, a window was cut in the pupal case, and pupae were mounted in slotted slides as previously described ([@bib39]; [@bib87]). At the specified developmental time point, IFMs were recorded every 0.65 s for 5 min. General movement within the thorax was distinguished from IFM-specific contraction, and each sample was scored for the number of single or double contractions observed per 5 min time window. Data were recorded in Excel and ANOVA was performed in GraphPad Prism to determine significant differences. Movies were assembled in Fiji (Image J), cropped and edited for length to highlight a selected twitch event.

Quantitative imaging of fosmid reporter intensity was performed at 30 hr APF, 48 hr APF, 72 hr APF, 90 hr APF and in 1 day adult in live IFM by normalizing to fluorescent beads (ThermoFisher (Molecular Probes), InSpeck Green Kit I-7219). IFMs were dissected from five flies, mounted with fluorescent microspheres (0.3% or 1% relative intensity, depending on the reporter intensity) in the supplied mounting medium and immediately imaged (within 20 min). Intensity measurements were obtained at 40x for at least 10 flies in regions where both IFM and at least three beads were visible. Control *Act88F-GAL4;; fosmid-GFP* x *w^1118^* and *Act88F*-GAL4*;; fosmid-GFP* x *salmIR* (fosmids used included *Strn-Mlck-GFP, Mhc-GFP, Fln-GFP*, and *Unc-89-GFP*) were imaged in the same imaging session. Relative fluorescence fiber to beads was calculated for each image in Fiji by averaging intensity for three fiber ROIs and three bead ROIs. Data were recorded in Excel and Student's t-test for significance and plotting were performed in GraphPad Prism.

mRNA-Seq {#s4-6}
--------

We previously published mRNA-Seq analysis of dissected IFMs from *Mef2*-GAL4, UAS-GFP-Gma x *w^1118^* at 30 hr APF, 72 hr APF and 1d adult, and *Mef2-GAL4, UAS-GFP-Gma* x *salmIR* in 1d adult ([@bib75]). We expanded this analysis in the present study to include myoblasts from third instar larval wing discs (see below) and dissected IFMs from *Mef2*-GAL4, UAS-GFP-Gma x *w^1118^* at 16, 24, 30, 48, 72, 90 hr APF and from 1 day adults as well as IFMs from *Mef2*-GAL4, UAS-GFP-Gma x *salmIR* flies at 24, 30, 72 hr APF and from 1 day adults. IFMs were dissected from groups of 15 flies in 30 min to minimize changes to the transcriptome, spun down in PBS for 5 min at 7500 rpm and immediately frozen in 100 µl TriPure reagent (\#11667157001, Roche) on dry ice. RNA was isolated after combining IFMs from 150 to 200 flies, with biological duplicates or triplicates for each time point.

Poly(A)+mRNA was purified using Dynabeads (\#610.06, Invitrogen) and integrity was verified on a Bioanalyzer. mRNA was then fragmented by heating to 94°C for 210 s in fragmentation buffer (40 mM TrisOAc, 100 mM KOAc, 30 mM MgOAc~2~). First-strand cDNA synthesis was performed with the Superscript III First-Strand Synthesis System (\#18080--051, Invitrogen) using random hexamers. The second strand was synthesized with dUTP and submitted to the Vienna Biocenter Core Facilities (VBCF, <http://www.vbcf.ac.at>) for stranded library preparation according to standard Illumina protocols and sequenced as SR100 on an Illumina HiSeq2500. Libraries were multiplexed two to four per lane using TrueSeq adaptors.

Wing disc sorting and myoblast isolation {#s4-7}
----------------------------------------

To perform mRNA-Seq on fusion competent myoblasts that will form the IFMs, we first dissected wing discs from wandering third instar larvae and manually cut the hinge away from the wing pouch. mRNA was isolated in TriPure reagent and sequenced as described above. We estimate this sample (Myo1) is \~50% myoblast, as the myoblasts form a nearly uniform layer over the underlying epithelial monolayer. To obtain a purer myoblast sample, we performed large-scale imaginal disc sorting followed by dissociation. We used particle sorting to isolate imaginal discs from *Him-*GAL4, UAS-BBM (UAS-palmCherry); *salm-*EGFP flies based on the green fluorescent signal. 10--12 ml of larvae in PBS were disrupted using a GentleMACS mixer (Miltenyl Biotec) and discs were collected through a mesh sieve (\#0278 in, 25 opening, 710 µm). Fat was removed by centrifugation for 10 min. at 1000 rpm at 4°C, discs were rinsed in PBS and then re-suspended in HBSS. Discs were further purified on a Ficoll gradient (25%:16%). Discs were then sorted on a Large Particle Flow Cytometer (BioSorter (FOCA1000), Union Biometrica, Inc.), obtaining 600--1000 discs per sample. Discs were spun for 5 min at 600 rcf in a Teflon Eppendorf tube and then re-suspended in the dissociation mixture (200 µl of 10x Trypsin, 200 µl HBSS, 50 µl collagenase (10 mg/mL), 50 µl dispase (10 mg/ml)). The tube was incubated for 10 min. at RT and then transferred to a thermal shaker for 30 min. at 25°C at 650 rpm. Myoblasts were filtered through a 35 µm tube-cap filter and spun at 600 rcf for 5 min. to pellet the cells. Cells were re-suspended in HBSS for evaluation or frozen in TriPure reagent for RNA extraction. We obtained samples with \~90% purity based on counting the number of red fluorescent cells/non fluorescent+green fluorescent cells in three slide regions. mRNA was isolated in TriPure reagent and sequenced as described above, generating the Myo2 and Myo3 samples.

Analysis of RNA-Seq data {#s4-8}
------------------------

FASTA files were de-multiplexed and base called using Illumina software. Reads were trimmed using the FASTX-toolkit. Sequences were mapped using STAR ([@bib14]) to the *Drosophila* genome (BDGP6.80 from ENSEMBL). Mapped reads were sorted and indexed using SAMtools ([@bib40]), and then bam files were converted to bigwig files. Libraries were normalized based on library size and read-counts uploaded to the UCSC Browser for visualization (<http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Ayeroslaviz&hgS_otherUserSessionName=IFMTP.leg.TCpaperHub1>; <http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Ayeroslaviz&hgS_otherUserSessionName=AretSalmIFMTP.TCpaperHub2>).

Mapped sequences were run through featureCounts ([@bib41]) and differential expression analysis was performed on the raw counts using DESeq2 ([@bib45]). We performed all pairwise comparisons across the time-course as well as between wild-type and *salmIR* samples ([Supplementary file 1](#supp1){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}). All original and processed data can be found as supplemental data or in the Gene Expression Omnibus submission (accession number GSE107247). R packages employed in the analysis include ComplexHeatmap ([@bib28]), CorrPlot (<https://github.com/taiyun/corrplot>), VennDiagram ([@bib10]), plyr ([@bib90]), reshape2 ([@bib88]), ggplot2 ([@bib89]) and RColorBrewer ([@bib49]).

Genome-wide soft clustering was performed in R with Mfuzz ([@bib22]), using the DESeq2 normalized count values. We filtered the dataset to include all genes expressed at one time point or more, defining expression as \>100 counts after normalization. We then set all count values \< 100 to 0, to remove noise below the expression threshold. DESeq2 normalized data was standardized in Mfuzz to have a mean value of zero and a standard deviation of one, to remove the influence of expression magnitude and focus on the expression dynamics. We tested 'k' ranging from 10 to 256. We then performed consecutive rounds of clustering to obtain three independent replicates with similar numbers of iterations, ultimately selecting a final k = 40 clusters with iterations equal to 975, 1064 and 1118. We calculated a 'stability score' for each cluster by calculating how many genes are found in the same cluster in each run ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Figures are from the 1064 iterations dataset. Mfuzz cluster core expression profiles were calculated as the average standard-normal expression of all genes with a membership value greater than or equal to 0.8, and then core profiles were clustered in R using Euclidean distance and complete linkage.

Enrichment analysis was performed with GO-Elite ([@bib92]) using available Gene Ontology terms for *Drosophila*. We additionally defined user provided gene lists for transcription factors, RNA binding proteins, microtubule associated proteins, sarcomeric proteins, genes with an RNAi phenotype in muscle ([@bib68]), mitochondrial genes (<http://mitoXplorer.biochem.mpg.de>) and *salm* core fibrillar genes ([@bib75]). Full results and gene lists are available in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. These user-supplied lists allowed us to define more complete gene sets relevant to a particular process or with a specific localization than available in existing GO terms. Analysis was performed with 5000 iterations to generate reliable significance values.

Data availability {#s4-9}
-----------------

Processed data from DESeq2, Mfuzz and GO-Elite are available in [Supplementary file 1](#supp1){ref-type="supplementary-material"}, [2](#supp2){ref-type="supplementary-material"}, [4](#supp4){ref-type="supplementary-material"}. mRNA-Seq data are publicly available from NCBI's Gene Expression Omnibus (GEO) under accession number GSE107247. mRNA-Seq read counts are further publicly accessible as track hubs in the UCSC Genome Browser at the following links: \[1\] (wild-type IFM time course) <http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Ayeroslaviz&hgS_otherUserSessionName=IFMTP.leg.TCpaperHub1> and \[2\] (salm timecourse) <http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=Ayeroslaviz&hgS_otherUserSessionName=AretSalmIFMTP.TCpaperHub2>. Fiji scripts for analysis of sarcomere length, myofibril width and myofibril diameter are available from <https://imagej.net/MyofibrilJ>. Raw data used to generate all plots presented in figure panels are available in the source data files for [Figures 1](#fig1){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}. Data on statistical test results are presented in [Supplementary file 5](#supp5){ref-type="supplementary-material"}.
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10.7554/eLife.34058.040

###### mRNA-Seq raw data

The file includes multiple tabs containing the raw or input counts data from bioinformatics analysis, as well as a key to all original data provided in the supplementary tables. This table includes mRNA-Seq counts data, DESeq2 normalized counts data and standard normal counts data used for Mfuzz clustering for wild-type and *salmIR* IFM time points. The averaged core expression profiles for each Mfuzz cluster are also listed.

10.7554/eLife.34058.041

###### GO-Elite analysis data.

This table includes multiple tabs containing the GO-Elite analysis of enrichments in Mfuzz clusters as well as genes up- or down-regulated from 30--72 hr APF and between wild-type and *salmIR* IFM. It also contains a complete list of all genes included in the 'User Defined' gene sets.

10.7554/eLife.34058.042

###### Summary of sarcomere and myofibril quantifications

This table includes a numerical summary of quantification values reported graphically in [Figures 5](#fig5){ref-type="fig"}, [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}. Quantifications of sarcomere length, myofibril width and myofibril diameter were performed with the MyofibrilJ script (see Materials and methods). Fiber length and cross-sectional area measurements were performed in Fiji/Image J.

10.7554/eLife.34058.043

###### DESeq2 pairwise differential expression analysis

This table contains multiple tabs containing the output data from DESeq2 differential expression analysis between sequential IFM development time points, from 30 to 72 hr APF as well as between WT and *salmIR* IFM.

10.7554/eLife.34058.044

###### Statistical Data

This table includes multiple tabs containing the statistical and calculation data for the different panels of [Figures 1](#fig1){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}.

10.7554/eLife.34058.045

Data availability {#s7}
-----------------

Processed data from DESeq2, Mfuzz and GO-Elite are available in Supplementary Files 1, 2, 4. mRNA-Seq data are publicly available from NCBI\'s Gene Expression Omnibus (GEO) under accession number GSE107247. Fiji scripts for analysis of sarcomere length, myofibril width and myofibril diameter are available from <https://imagej.net/MyofibrilJ>. Raw data used to generate all plots presented in figure panels are available in the source data files for Figures 1, 5, 6, 7 and 8. Data on statistical test results are presented in Supplementary File 5.

The following dataset was generated:

Spletter MLSchnorrer FYeroslaviz AStark AHabermann B2017Systematic transcriptomics reveals a biphasic mode of sarcomere morphogenesis in flight muscles regulated by Spalt<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107247>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE107247).

The following previously published dataset was used:

Spletter MLSchnorrer FGerlach DStark AYeroslaviz AHabermann B2014The RNA binding protein Arrest (Aret) regulates myofibril maturation in Drosophila flight muscle<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63707>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE63707).

10.7554/eLife.34058.051
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Thank you for submitting your article \"Systematic transcriptomics reveals a biphasic mode of sarcomere morphogenesis in flight muscles regulated by Spalt\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior/Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Systematic transcriptomics reveals a biphasic mode of sarcomere morphogenesis in flight muscles regulated by Spalt by Spletter et al., addresses an important issue of global gene expression underlying development of *Drosophila* indirect flight muscle (IFM), which represent an attractive model for multi-fibrillar muscle formation in general. Even if developmental time points used for transcriptomics cover the entire myogenic process, authors focus here mainly on myofibrillogenesis and sarcomerogenesis that take place from 30 h APF until the end of pupa stage. Using dedicated bioinformatics tools they identify a large number of gene clusters that display similar temporal profiles of expression and among them clusters No. 13 and No. 22 enriched in genes encoding sarcomeric components. For example genes from cluster 22, characterized by an increase in expression between 48 and 72h, include Mhc, Act88F and Mf. In parallel, authors present a detailed view of different steps of IFM formation largely based on in vivo imaging of IFM development and on expression analyses of sarcomeric components at protein levels. Based on transcriptional profiling showing that expression of a number of sarcomeric transcripts peak at 72 h APF but also on the observations that some sarcomeric components (Mhc, Obscurin) could be detected at protein levels as early as at 30 h APF authors propose that sarcomerogenesis involves 2 phases: i) formation of immature sarcomeres; ii) sarcomere maturation.

Authors also try to correlate their time-course transcriptional data in the developing IFMs with gene deregulation in the context of late Salm knockdown and conclude that Salm in addition to its role in the specification of fibrillar muscle fate is also required for the sarcomere maturation in flight muscles. Altogether, the manuscript is rich in large-scale data and well illustrated providing many quantitative assessments of developing myofibrils and sarcomeres over time. It could thus represent an important resource for the community of muscle research. This paper is also technically sound (but see specific major comments) and will be an excellent resource for scientists interested in muscle development. Unfortunately, it wants to be more than a resource paper, and the statements in the title are not supported by evidence. An important concern is the author\'s interpretation of sarcomere formation that they propose to be biphasic and several of our points relate to this is different ways. Further, one gets the feeling that the *salm* data was simply added, because this was already a familiar gene to the authors. The *stretchin* data (Figure 7 and 8) are also somewhat unmotivated: *stretchin* knockdown has a stronger phenotype than *salm* knockdown, even though *salm* is supposed to upregulate dozens of sarcomeric genes in addition to *stretchin*.

In summary, these and the points below lead us to the conclusion that as a resource, this paper is great, and there are many hidden gems, e.g. the down-regulation of microtubule genes after the sarcomere formation phase (after 30h APF), which could indicate an involvement of MTs in setting up initial myofibril polarity as suggested by Reedy and Beall. However, the authors try to over- interpret their results and the title and interpretation are somewhat disconnected with what the data allows.

Given the value as a resource, the authors should substantially re-write the paper accordingly. It does not make it any less of value, indeed makes it value greater.

Essential revisions:

The first three points address the same issue.

1\) When looking at all the presented data one could rather conclude that sarcomere formation is a continuous process tightly correlated with myofibrillogenesis and involving 3 distinct steps: a. simultaneous formation of first set of immature sarcomeres (here 80) during compaction force-driven formation of myofibrils at 30 h APF. b. Increasing myofibrils length by adding of immature sarcomeres (up to 230) between 30 and 48 h APF -- here according to the scheme (Figure 9) immature sarcomeres are already more complex and longer than those formed initially; c. Increasing myofibrils length and diameter by incorporating to the sarcomeres of additional "core" components (e.g. Mhc) and muscle-type specific components (e.g. Mf, Fln) Thus, the first phase authors call "sarcomere formation" between (30 and 48 h APF), already includes some maturation events. Also, the model presented in Figure 9 fits rather into a 3 step continuous process.

2\) In a slightly different perspective on the \'biphasic expression\': As mentioned above, both the transcriptional data and bioinformatics analysis are we\'ll done. However, despite the accurate bioinformatics and clustering data there is not enough novelty regarding the difference between the two phases of flight muscle development and how they are regulated. The data presented are based on correlations between the distinct clusters and distinct stages of muscle maturation and remain at the level of parallel observations. As the authors discuss, many of the observations have already been previously described, even by the authors themselves. The link between myofibrillogenesis and transcription of muscle proteins is trivial. Does transcription at the second phase depends on muscle mechanics, or it only represents the need for the muscle to grow in size. Are distinct factors control the first versus the second phase? Moreover, as the authors note in their Discussion, large scale transcriptomic changes have already reported during mouse, pig, and fish skeletal muscles growth, so the additional novelty of the present study is not entirely clear. The observation that Salm is required for the late stage of sarcomere maturation and growth is interesting, however, the authors did not elaborate on how the same transcription factor promotes two distinct phases of sarcomere development. Is it the levels of Salm, or its putative cooperation with additional factors that are present only in the second phase? Could it be that the differential mechanical inputs together with Salm transcriptional input change the outcome?

3\) And in a third view on the same theme: The authors distinguish a sarcomere formation phase followed by a sarcomere maturation phase. They give as an example cluster 22, which they say is strongly up-regulated in the maturation phase. What we can see is a gradual up-regulation of all of these genes starting at around 24h-30h APF (sarcomere formation) with a peak shortly before hatching, which corresponds precisely to the progression of muscle development as laid out in Figure 1, and is not surprising. To make all this muscle mass, massive transcription of cytoskeletal genes is required. To spell out one example, the Mhc gene: according to Supplementary file 1, sheet 2, Mhc at 30h (570173) is already 600-fold up-regulated compared to 16h (931). That is, Mhc is very strongly expressed when sarcomeres form (as it should be), and becomes even more massively expressed, when myofibrils grow in length and volume. The same applies to most other sarcomeric genes. The authors say this biphasic mode is regulated by *salm*. Or, to rephrase, the massive up-regulation from 48-90h APF is due to *salm*. This does not fit with their own data. Salm has an expression peak at 72h APF (cluster 26), too late to cause the massive up-regulation starting at 30h APF, and correspondingly, their knock-down data (Figure 6) are unconvincing. The authors stress that this is likely a general mechanism of muscle development, but provide no evidence. Rather, one of the interesting effects that *salm* knockdown has (muscle contractions do not stop at 72h in *salm* knockdown IFM in Figure 7) is clearly specific to IFM, because other muscles (embryonic or abdominal) contract increasingly strongly throughout development.

4\) Figure 1 -- No legend to schemes presenting different steps of DLM development (last column) is provided. What does the blue drawing represent? If this corresponds to Shot expression, its presence on the scheme at 16 h APF does not fit with the immunostaining (B\').

5\) Figure 1 -- How was the length of wavy fibers at 90 h APF determined;

6\) Figure 2 and Figure 2---figure supplement 2 -- temporal Aret expression profile (cluster 14) appears different from that of its activator Salm (cluster 26).

7\) Figure 2---figure supplement 2 -- Salm transcripts level are up-regulated at 30h but down at 48h. At protein levels 30h is not presented but immunostaining at 48 h shows high protein accumulation -- higher than at 72 h when the mRNA peak is highest. The authors need to comment this discrepancy -- could it be related to technical issues/quality of biological sample for transcriptional profiling?

8\) Figure 2. -- Also, RNA profile and protein detection of Talin do not correlate. βPS-integrin seems to be a better example and could move to the main figure instead of Talin.

9\) Figure 2---figure supplement 1 -- Number of different temporal profiles -- 40 clusters appears high. This is certainly related to constrain when using Mfuzz. Some of clusters look similar. Did authors try to analyse their data with less clusters?

10\) Figure 3 is not particularly important for the data analysis and could be moved to supplementary data.

11\) Figure 5---figure supplement 1 -- How do the authors explain detection of Mhc and Obscurin at 30h in the sarcomeres even if their transcripts are not detected (or have we missed something here?)?

12\) Figure 7 and 8 -- Strn-Mlck appears to be the main target of Salm during the maturation phase, Strn-Mlck expression is reduced in sarcomeres from Act88F\>salmIR pupae, however effects of Salm loss of function leads to a reduced sarcomere size while in Strn-Mlck mutants at 90 h APF sarcomeres are much longer. These differences of phenotypes are surprising and suggest that Strn-Mlck is not the major Salm target in the second phase. Did authors test other potential candidates whose function fits better with that of late Salm phenotypes?

13\) Figure 9 -- Use in the scheme only sarcomeric components analysed in this work or refer to published data if you include others.

14).Other comments: In Supplementary file 1, sheet 1, the cluster assignment is incorrect: e.g. unc-89 is listed as cluster 24 (should be 13), Mhc is listed as cluster 39 (should be 22), etc.

15\) Figure 1 and 5 are beautiful and quantitatively very rigorous, but essentially repeat what we know since Reedy and Beall (1993) and more recent publications from the Schnorrer lab.

10.7554/eLife.34058.052

Author response

> \[...\] Unfortunately, it wants to be more than a resource paper, and the statements in the title are not supported by evidence. An important concern is the author\'s interpretation of sarcomere formation that they propose to be biphasic and several of our points relate to this is different ways.

We agree with the reviewers' comment that the biphasic model was an over-simplification of our observations and we apologize for that. A more accurate interpretation of our observations is 1) around 80 immature sarcomeres assemble simultaneously in each myofibril at about 30 h APF; 2) around 200 new sarcomeres are added to each immature myofibril as they grow and develop until about 48 h APF; 3) subsequently, as the myofibrils/sarcomeres continue to mature, they grow significantly in length and diameter, but *no* new sarcomeres are being added (at least not after 60 h APF).

Taking this into account, we now define three ordered but also continuous phases, so we now call them sequential but overlapping phases 1) simultaneous sarcomere assembly phase at 30-34 h APF; 2) sarcomere addition/maturation phase until shortly after 48 h and 3) sarcomere growth and maturation phase until adulthood.

Importantly, our work discovered that new myofibrils are only assembled at 30 h APF: we quantified the number of myofibrils per muscle fiber, which remains constant after 30 h APF. This suggests that the adult fly is equipped with myofibrils which all originate from the first simultaneous assembly phase. Hence, we believe it is significant to define these sequential phases, making our manuscript different from a classical \'resource paper\'. However, as the reviewers and editor suggested, we also find our paper appropriate for the *eLife* \'resource section\'. We have adjusted the title and content accordingly and hope the new title faithfully represents the results.

> Further, one gets the feeling that the salm data was simply added, because this was already a familiar gene to the authors.

Our work identified a transcriptional transition after 30 h APF, with many genes including two clusters (13 + 22) enriched for sarcomere protein coding genes, whose expression is boosted after 30 h APF. To understand these transcriptional dynamics mechanistically, we tested a number of candidate regulators, including Mef2, E2F, Salm and Him, however only Salm led to conclusive results. We show that Salm is required for full induction of the transcriptional transition after 30 h APF at the systems level. We have verified the Salm-dependent induction of a number of sarcomeric proteins, including Stretchin, Flightin and Mhc, at the protein level. As this was performed using quantitative microscopy of protein fusions under endogenous control, we believe our data significantly supports that the observed transcriptional transition is at least in part regulated by Salm. Thus, we feel the *salm* RNAi data do fit well to the rest of the manuscript and provide a first mechanistic explanation of parts of the transcriptional dynamics observed. However, we agree with the reviewers that Salm is not the only regulator as the transition is not entirely blocked in *salm* RNAi, and thus we adjusted the title and statements throughout the manuscript to make clear that Salm as well as other genes contribute to the regulation. This is also addressed more clearly in the Discussion.

We have further updated our curated 'sarcomere protein list' to more accurately represent structural sarcomeric proteins, as the previous list contained some non-sarcomeric genes, such as microtubule binding proteins and RNA binding proteins, that potentially influence sarcomere assembly. The new list is included in Supplementary file 2, and all of the bioinformatics panels and enrichment analyses throughout the manuscript have been updated to reflect the new list.

> The stretchin data (Figure 7 and 8) are also somewhat unmotivated: stretchin knockdown has a stronger phenotype than salm knockdown, even though salm is supposed to up-regulate dozens of sarcomeric genes in addition to stretchin.

Stretchin is one of the strongest induced mRNAs after 30 h APF. It is first detectable on the protein level at 48 h APF and is extremely high expressed at 72 h APF onwards. Thus, it is not only connected to the observed transcriptional transition, but a bone fide example of it. As the reviewers point out correctly, Salm regulates many sarcomeric genes. This is likely the explanation why the *stretchin* loss of function phenotype is different to the *salm* RNAi phenotype. However, the *stretchin* loss of function phenotype is *not* stronger than the *salm* RNAi phenotype. In *salm* RNAi, sarcomere growth is reduced already after 48 h APF, whereas in the *stretchin* mutant the sarcomeres overgrow at 80 h APF and only later muscle hypercontraction results in too short sarcomeres in the adult *stretchin* mutants. We made this difference more clear in the revised version of the manuscript. However, we believe that both aspects, the *salm* RNAi and the *stretchin* mutant data, fit very well to the transcriptional transition of the sarcomeric protein coding genes identified in the first part of the manuscript.

> In summary, these and the points below lead us to the conclusion that as a resource, this paper is great, and there are many hidden gems, e.g. the down-regulation of microtubule genes after the sarcomere formation phase (after 30h APF), which could indicate an involvement of MTs in setting up initial myofibril polarity as suggested by Reedy and Beall. However, the authors try to over- interpret their results and the title and interpretation are somewhat disconnected with what the data allows.
>
> Given the value as a resource, the authors should substantially re-write the paper accordingly. It does not make it any less of value, indeed makes it value greater.

We are happy that the reviewers appreciate the importance of our study as a resource. Apart from the early microtubule cluster or various mitochondrial clusters, our data for example also contains expression dynamics of all RNA binding protein or transcription factors. We have decided to focus on the two clusters enriched for sarcomere protein coding genes in this manuscript, and thus included the biological findings related to these, which we would like to keep together. As explained above, we have reworked our manuscript including its interpretation and hope that this revised version appears suitable for publication in *eLife* as a resource with strong biological implications.

> Essential revisions:
>
> The first three points address the same issue.
>
> 1\) When looking at all the presented data one could rather conclude that sarcomere formation is a continuous process tightly correlated with myofibrillogenesis and involving 3 distinct steps: a. simultaneous formation of first set of immature sarcomeres (here 80) during compaction force-driven formation of myofibrils at 30 h APF. b. Increasing myofibrils length by adding of immature sarcomeres (up to 230) between 30 and 48 h APF -- here according to the scheme (Figure 9) immature sarcomeres are already more complex and longer than those formed initially; c. Increasing myofibrils length and diameter by incorporating to the sarcomeres of additional "core" components (e.g. Mhc) and muscle-type specific components (e.g. Mf, Fln) Thus, the first phase authors call "sarcomere formation" between (30 and 48 h APF), already includes some maturation events. Also, the model presented in Figure 9 fits rather into a 3 step continuous process.

We thank the reviewers for this point to which we entirely agree. As explained above, we have reworked our manuscript to now present 3 sequential but overlapping phases. By definition, 3 phases need to be somewhat distinct from each other -- otherwise it would only be one phase. However, the 3 phases are connected and there is no sharp switch, thus we call them now sequential phases. We incorporated these points into the revised version of our manuscript.

> 2\) In a slightly different perspective on the \'biphasic expression\': As mentioned above, both the transcriptional data and bioinformatics analysis are we\'ll done. However, despite the accurate bioinformatics and clustering data there is not enough novelty regarding the difference between the two phases of flight muscle development and how they are regulated. The data presented are based on correlations between the distinct clusters and distinct stages of muscle maturation and remain at the level of parallel observations. As the authors discuss, many of the observations have already been previously described, even by the authors themselves.

We believe that not only the systematic transcriptomics but also the sequential phases of myofibrillogenesis are first described in quantitative detail in this manuscript. We quantified the length of the muscle fibers, the sarcomeres and consequently the number of sarcomeres per myofibril much more carefully than earlier work by Reedy and Beall (1993), which was done at 22 degrees, so is also difficult to relate to our transcriptomics time‐points. In particular, the cross sections in which we have also analyzed myofiber (muscle) diameter fueled the discovery that myofibrils are only built once, at 30h APF. In turn, we conclude that all myofibrils in the adult must progress through the sequential phases during development. Thus, our manuscript contains novel data that sparked novel conclusions, which in our opinion are important points of the manuscript.

> The link between myofibrillogenesis and transcription of muscle proteins is trivial. Does transcription at the second phase depends on muscle mechanics, or it only represents the need for the muscle to grow in size. Are distinct factors control the first versus the second phase? Moreover, as the authors note in their Discussion, large scale transcriptomic changes have already reported during mouse, pig, and fish skeletal muscles growth, so the additional novelty of the present study is not entirely clear. The observation that Salm is required for the late stage of sarcomere maturation and growth is interesting, however, the authors did not elaborate on how the same transcription factor promotes two distinct phases of sarcomere development. Is it the levels of Salm, or its putative cooperation with additional factors that are present only in the second phase? Could it be that the differential mechanical inputs together with Salm transcriptional input change the outcome?

We have not tested if the transcriptional change after 30 h APF depends on muscle forces/mechanics. This is certainly an interesting aspect to investigate in the future. We thank the reviewers for pointing it out, but we believe it is beyond the scope of our current manuscript.

Transcriptional dynamics of some other muscles systems have been reported (much less quantitatively and systematically, as compared to our report here, and mainly restricted to postembryonic muscle growth), but very little is known about the mechanism instructing the change in transcription. We attempted to address this by investigating the role of Salm during the transcriptional transition. In the future, it will be exciting to see if this part of Salm's function requires contractile muscle force or not, as well as to identify additional factors regulating other stages of myofibril development. We have added this idea to the Discussion part of our manuscript, where we already discuss the possibility that Salm may cooperate with additional factors, such as E2F, which is also required at this late stage of muscle development (Zappia and Frolov, 2016).

> 3\) And in a third view on the same theme: The authors distinguish a sarcomere formation phase followed by a sarcomere maturation phase. They give as an example cluster 22, which they say is strongly up-regulated in the maturation phase. What we can see is a gradual up-regulation of all of these genes starting at around 24h-30h APF (sarcomere formation) with a peak shortly before hatching, which corresponds precisely to the progression of muscle development as laid out in Figure 1, and is not surprising. To make all this muscle mass, massive transcription of cytoskeletal genes is required. To spell out one example, the Mhc gene: according to Supplementary file 1, sheet 2, Mhc at 30h (570173) is already 600-fold up-regulated compared to 16h (931). That is, Mhc is very strongly expressed when sarcomeres form (as it should be), and becomes even more massively expressed, when myofibrils grow in length and volume. The same applies to most other sarcomeric genes.

The reviewer is correctly pointing out that Mhc is already expressed at 30 h APF (in contrast to 16 h APF). As said, this was expected, as myofibrils assemble at 30 h APF. However, it was much less expected, at least for us, to find the strong induction after 30 h APF, in particular as all myofibrils are already present at 30 h APF. There is a 2-fold log~2~FC for Mhc from 24h to 30h, but another 3-fold log~2~FC from 48h to 72h (so as strong if not stronger induction at the later stage). Additionally, some sarcomeric protein coding genes, like Stretchin, Myofilin and Flightin, are only expressed after 30 h APF and the proteins are not detectable at 30 h APF, at least not with our GFP fusion proteins expressed under endogenous control. See also the new data in Figure 6---figure supplement 3 quantifying the level of protein expression at the same developmental stages. Thus, the transition after 30 h APF is an active process (and not just doubling or tripling of mRNAs that are present before), which at least for us is interesting, novel and unexpected. Additionally, we linked the transcriptional transition to the functional change of gaining stretch activatability in flight muscles. Thus, the transition clearly has functional consequences.

> The authors say this biphasic mode is regulated by salm. Or, to rephrase, the massive up-regulation from 48-90h APF is due to salm. This does not fit with their own data. Salm has an expression peak at 72h APF (cluster 26), too late to cause the massive up-regulation starting at 30h APF, and correspondingly, their knock-down data (Figure 6) are unconvincing.

The transcriptional dynamics of Salm are consistent with a role of Salm in the observed transcriptional transition after 30 h APF. We showed with semi-quantitative imaging of Salm protein that Salm protein is expressed at 17 h APF, and protein levels strongly increase until 48 h APF, before they get down-regulated at 72 h APF (Figure 2---figure supplement 2C‐C''). These protein dynamics are also consistent with a *salm* mRNA peak at 30 h APF (protein is high at 48 h APF). The mRNA peak at 72 h APF may indicate a role even later in the process, which we have not investigated (see also comment below). Obviously, protein expression can be regulated post-translationally, hence confirmation at the protein level is important. In summary, we show high levels of *salm* mRNA at 30 h and of Salm protein at 48 h, both of which are consistent with a role of Salm in the transcriptional transition after 30 h APF. This transition is attenuated in *salm* RNAi muscle. We showed this bioinformatically using mRNA data at the systems level, and individually for selected candidates at the protein level (Figure 6). To make the bioinformatics in Figure 6 visually clearer, we have added violin plots to more clearly illustrate the decrease in expression of particular gene sets in *salmIR* and to emphasize that many of these genes, from cluster 22 for example, also fail to be induced as strongly from 30 h to 72 h APF compared to wild type. Further, to make our fluorescent protein expression data more convincing, we have added Figure 6---figure supplement 3, in which we detail time-course expression data for Mhc-GFP, Unc-89-GFP, Fln-GFP and Strn-Mlck-GFP using the fluorescent bead assay. These data quantify the strong increase in protein expression from 30 h to 72 h APF for these proteins, as well as provide a basis to judge how significant the decrease in protein expression is in *salmIR* muscle. We also show that a decrease in expression in the case of *Mef2*-GAL4\>Gma-GFP is detectable. We believe these additions should make the knock-down data in Figure 6 more convincing. However, we do agree that Salm is not inducing the transition in expression alone, as there is still transcriptional up-regulation in the absence of Salm. We have adjusted the text and the title accordingly in the revised manuscript.

> The authors stress that this is likely a general mechanism of muscle development, but provide no evidence. Rather, one of the interesting effects that salm knockdown has (muscle contractions do not stop at 72h in salm knockdown IFM in Figure 7) is clearly specific to IFM, because other muscles (embryonic or abdominal) contract increasingly strongly throughout development.

We suggest that the observed transcriptional transition during sarcomere development corresponding to sarcomere maturation is a general mechanism, as for example during vertebrate muscle development there is a reported transcriptional switch from embryonic to fetal myosin genes at specific stages, which likely influence sarcomere function and structure (Schiaffino and Reggiani, 2011). We are now more specific on this point in the Discussion of our revised manuscript.

The specific *salm*‐dependent gain of stretch-activation, which we have shown here for the first time, is indeed a flight muscle-specific feature. We make no claim that this particular change is general. However, the vertebrate heart also does acquire significant stretch activation capacity during development, as described by the Frank-Starling mechanism of heart contraction (Shiels et al. J. Exp Biol. 2008).

> 4\) Figure 1 -- No legend to schemes presenting different steps of DLM development (last column) is provided. What does the blue drawing represent? If this corresponds to Shot expression, its presence on the scheme at 16 h APF does not fit with the immunostaining (B\').

We apologize for missing description of the schemes in the legend. In blue are the tendon cells, which do express Shot protein, but as the reviewer pointed out, Shot is also expressed in the muscle. We have modified the legend accordingly.

> 5\) Figure 1 -- How was the length of wavy fibers at 90 h APF determined;

As described in the Materials and methods section, we have traced the edges of the myofiber from one attachment site to the other using the freehand tool in Fiji.

> 6\) Figure 2 and Figure 2---figure supplement 2 -- temporal Aret expression profile (cluster 14) appears different from that of its activator Salm (cluster 26).

Both *aret* and *salm* show an mRNA expression peak at 30 h APF. We show that Salm protein is already expressed at 17 h APF, at which stage only little of Aret protein is found compared to 24 h APF (Figure 2D-F, Figure 2---figure supplement 2A-C). This is consistent with Salm protein regulating *aret* mRNA expression (as shown in Spletter et al., 2015).

> 7\) Figure 2---figure supplement 2 -- Salm transcripts level are up-regulated at 30h but down at 48h. At protein levels 30h is not presented but immunostaining at 48 h shows high protein accumulation -- higher than at 72 h when the mRNA peak is highest. The authors need to comment this discrepancy -- could it be related to technical issues/quality of biological sample for transcriptional profiling?

We have no information about Salm protein turn-over rates at this point. It is conceivable that Salm protein stability may change after 48 h APF, explaining the drop in protein levels. Generally, in our mRNA-seq data transcription factors are expressed at much lower read-counts than structural proteins, hence these data can be indeed more variable. We have added a comment to the manuscript suggesting that the peak at 72 h of *salm* mRNA would need to be verified.

> 8\) Figure 2. -- Also, RNA profile and protein detection of Talin do not correlate. βPS Integrin seems to be a better example and could move to the main figure instead of Talin.

We agree with the reviewer and have switched Talin with βPS-Integrin to illustrate the point better in the main part of the figure. Thanks.

> 9\) Figure 2---figure supplement 1 -- Number of different temporal profiles -- 40 clusters appears high. This is certainly related to constrain when using Mfuzz. Some of clusters look similar. Did authors try to analyse their data with less clusters?

We comment on this issue in the Materials and methods section of the manuscript. We have systematically tested Mfuzz clustering with cluster numbers ranging from 5 to 250. After extensive tests, we decided that 40 is the best compromise to represent the complexity of the transcriptional dynamics and distinct clusters are well resolved. A lower number of clusters results in a merging of clusters, whose individual gene members show quite distinct temporal profiles.

> 10\) Figure 3 is not particularly important for the data analysis and could be moved to supplementary data.

We agree with the reviewer that Figure 3 is not essential for the data analysis. However, if space allows we would like to keep it in the main text, as it provides a good overview for the general reader, who is interested in other aspects of muscle biology apart from sarcomeres. In particular, for the 'resource section' of *eLife*, this figure would be important, as it amongst other things illustrates the dynamics of the early' microtubule clusters' or the various mitochondrial pathways for the general reader.

> 11\) Figure 5---figure supplement 1 -- How do the authors explain detection of Mhc and Obscurin at 30h in the sarcomeres even if their transcripts are not detected (or have we missed something here?)?

As discussed above, Mhc and Obscurin mRNAs are expressed at 30 h APF, but compared to 48 h APF the levels are low. This is illustrated by the small increase in the slope of the mRNA profile plots in Figure 2Q and Figure 2---figure supplement 2K from 16 h to 24 h to 30 h APF. It is also clear from Supplementary file 1 that contains all the mRNA read counts, that Mhc and Obscurin mRNA are present at a low level already at 30 h APF. We have adjusted the figure legend to make this more clear in the revised version.

This confusion illustrates well why we are so excited about this strong transcriptional induction, which we did not expect. Expression of many sarcomeric protein coding genes at 48 h APF is so high that the existing expression at 30 h APF is hard to see even on the log-scale plot profile that we show.

> 12\) Figure 7 and 8 -- Strn-Mlck appears to be the main target of Salm during the maturation phase, Strn-Mlck expression is reduced in sarcomeres from Act88F\>salmIR pupae, however effects of Salm loss of function leads to a reduced sarcomere size while in Strn-Mlck mutants at 90 h APF sarcomeres are much longer. These differences of phenotypes are surprising and suggest that Strn-Mlck is not the major Salm target in the second phase. Did authors test other potential candidates whose function fits better with that of late Salm phenotypes?

Stretchin is indeed one of many genes that are regulated by Salm after 30 h, thus removing a single target should not easily recapitulate the phenotype of the regulator. As sarcomere length is always a balance between thin and thick filament growth, as well as thin and thick filament overlap, it is not simple to relate sarcomere length differences directly to molecular differences. After eclosion, muscle fibers are hyper-contracted in both genotypes (*salm* RNAi and *stretchin* mutants), and sarcomeres are indeed too short in both genotypes at this stage.

We have not extensively tested other sarcomeric proteins for their function after 30 h APF.

> 13\) Figure 9 -- Use in the scheme only sarcomeric components analysed in this work or refer to published data if you include others.

We thank the reviewer for pointing this out. We added additional references.

> 14\) Other comments: In Supplementary file 1, sheet 1, the cluster assignment is incorrect: e.g. unc-89 is listed as cluster 24 (should be 13), Mhc is listed as cluster 39 (should be 22), etc.

We apologize for this mistake. The table was from an earlier version. We fixed it in the revised version and thank the reviewer for finding our mistake.

> 15\) Figure 1 and 5 are beautiful and quantitatively very rigorous, but essentially repeat what we know since Reedy and Beall (1993) and more recent publications from the Schnorrer lab.

As discussed above, these careful quantifications, including the cross-sections at the corresponding stages, were essential for a key discovery of the manuscript -- myofibrils are assembled only once and their number remains constant after 30 h APF. This finding sparked the idea of the subsequent sarcomerogenesis/ myofibrillogenesis phases, since all myofibrils are made initially, then need to grow by adding more sarcomeres, and finally individual sarcomeres grow in length and diameter. Such an analysis had not been done before, however we certainly do cite the earlier work that inspired our new studies.

Additionally, we present a novel script for semi-automated analysis of sarcomere length and myofibril width, allowing us to trace changes in these parameters at a higher resolution and across more time points than previously reported. Lastly, we present a completely novel finding in Figure 5I-J that IFMs spontaneously contract during development but lose this ability by 72 h APF. This finding more broadly impacts how we think about myofibril development and the establishment of stretch-activation in muscle fibers.
